新疆乙型肝炎病毒的基因亚型、变异的研究
|
摘要
HBV是环境中存在的一种对人致病性较强的病毒。HBV感染后常可引起急性和慢性肝炎,肝硬化甚至肝癌,是中国现阶段最为突出的公共卫生问题之一。慢性肝炎病毒(HBV)感染呈世界性流行。我国属HBV感染高流行区。
HBV具有易变性及准种的特性。目前,根据HBV全基因组序列差异≥8%或S基因序列≥4%,将HBV分为A、B、C、D、E、F、G、H等8个基因型。HBV基因型有明确的地理和人种的分布特征。HBV在慢性感染过程中,变异可自发产生,也可在体内因宿主免疫压力或药物压力下而产生。如慢性乙型肝炎可因前C区变异和/或C区基因变异,不表达HBeAg而分为HBeAg阳性和HBeAg阴性两大类。HBV C基因基本核心基因启动子变异(BCP)和前C区变异(PC),可能与肝病严重程度有关。也具有一定的地域分布差别。HBV聚合酶有四个功能区,其中RT区有7个催化功能的基序,依次称为G、F、A、B、C、D、E区,其中,B、C、D区是P基因耐药变异最常见的部位。不同的核苷类似物耐药株的变异位点不同。
新疆是个多民族居聚区,HBV感染及疾病谱有其特殊性。研究表明,新疆维吾尔族HBV基因型以D基因型为多,与我国内地以B、C基因型为主的流行情况有所不同,为进一步证实新疆地区的不同民族HBV感染者的基因型分布特征,了解新疆不同民族的基因亚型的分布,前C区变异和C区变异,耐药变异等情况,为今后防治HBV奠定了理论的基础。目的:进一步证实新疆慢性HBV感染者的HBV基因型分布特征,了解新疆不同民族的基因亚型,PC、BCP变异及耐药变异的特征,为进一步研究防治HBV提供科学依据。尤其是研究新疆HBV感染者基因型、亚型分布有无特征。新疆HBV感染者的HBV PC变异和BCP变异与HBV感染病情严重性和HBeAg阴性有无关联性。了解P基因区变异与HBV不同基因型是否有联系以及抗病毒药物效果与P基因区变异之间的关系,旨在为今后防治HBV感染提供科学依据。
方法:
收集331例新疆慢性HBV感染者的血清,其中慢性乙型肝炎(CHB)240例,乙肝肝硬化(LC)64例,肝癌(HCC)27例。
1)采用聚合酶链反应限制性片段长度多态性(PCR-RFLP)方法,进行基因型、基因亚型、PC变异、BCP变异的检测,并对部分标本用直接测序法进行验证,所得的测序结果采用生物信息学技术进行分析比较。
2)对随机选择的14例标本进行全基因测序,选择14例用核苷类似物治疗的CHB及4例未用核苷类似物的标本进行P基因区测序,然后用生物信息学技术进行分析并与基因库进行比对分析。
结果:
1)用PCR-RFLP技术对新疆331例HBV感染者的HBV基因型、基因亚型进行检测,随机选取部分标本用直接测序法验证。结果显示331例慢性HBV感染者的HBV基因型为:B基因型12.7%,C基因型64%,C/D重组体16%,D基因型7.3%。进一步检测基因亚型显示B基因亚型均为Ba亚型,未检测到Bj亚型。在C基因型中,C1亚型42.9%,C2亚型57.1%。不同民族基因型分析显示,在汉族HBV感染者中,B基因型14.9%,C基因型72.9%,C/D重组体9.5%,D基因型2.7%,而维吾尔族HBV感染者中B基因型8.3%,C基因型45.9%,C/D重组体29.4%,D基因型16.5%。维吾尔族与汉族比较,基因型分布有差别(P<0.05)。进一步基因亚型结果显示Ba亚型中,汉族78.6%,维吾尔族21.4%。C基因亚型汉族76.4%,其中,C1亚型39.5%,C2亚型60.5%;而维吾尔族23.6%,C1亚型54%,C2亚型46%。在不同临床类型中,慢性乙型肝炎中,C1亚型26.7%,C2亚型33.3%。在乙肝肝硬化中,C1亚型30%,C2亚型45.3%。在肝癌中,C1亚型30.8%;C2亚型46.2%。
2)用PCR-RFLP技术检测HBV PC变异和BCP变异结果显示,PC变异30.2%,BCP变异34.4%。进一步比较PC变异和BCP变异,在不同亚型分布显示,Ba亚型中PC变异35.7%,BCP变异28.6%;C1亚型中PC变异37.4%,BCP变异41.8%;C2亚型PC变异25.6%,BCP变异31.4%;C/D重组体PC变异20.8%,BCP变异35.8%。C1亚型BCP变异明显高于Ba亚型,有统计学意义(P<0.05),PC变异在各亚型中无明显差别(P>0.05)。维吾尔族HBV感染者中,Ba亚型PC变异1.8%,BCP变异5.5%;C1亚型PC变异3.7%,BCP变异11%;C2亚型PC变异5.5%,BCP变异7.3%;C/D重组体PC变异6.4%,BCP变异12.8%,C/D重组体的PC变异、BCP变异明显高于Ba亚型,差异有统计学意义(P<0.01)。C1亚型、C2亚型介于两者之间。
3)使用PCR-RFLP技术对HBV PCR-测序方法,对14例病人进行全基因的测序。全基因测序证实2例C/D重组体,12例D基因型与RFLP方法保持一致。测序结果显示2例C/D重组体,12例D基因型与GenBank现有的序列有差异。全部在GenBank上收录。4)用PCR-测序方法,对新疆18例HBV感染者的HBV P基因区测序,采用
生物信息学技术进行分析,在P基因区变异结果显示,14例服用阿德福韦治疗,CHB标本中有13例出现P基因区变异。进一步分析显示,主要在聚合酶B区附近的变异(16个)和D区(6个)附近。
5例C1亚型在聚合酶B区附近的变异有9个;聚合酶D区附近的变异有1个。5例C2亚型在聚合酶B区附近的变异有3个;聚合酶D区附近的变异有3个。6例Ba亚型在聚合酶B区附近的变异有4个;聚合酶D区附近的变异有8个。1例D基因型在聚合酶B区附近的变异有3个;聚合酶D区附近的变异有1个。1例C/D1亚型在聚合酶B区附近的变异2个。34例YMDD变异中,B基因型11.8%,C基因型64.7%,C/D基因型20.6%例,D基因型2.9%,提示C基因型易出现YMDD耐药变异。在基因亚型中,10例C1亚型45.4%,12例C2亚型54.5%,YMDD变异在C2亚型比C1亚型的多。
结论:
1)新疆地区331例HBV感染者的HBV采用PCR-RFLP方法,部分标本测序验证,采用生物信息学技术进行分析,结果显示新疆HBV基因型以C基因型为主,且以C2亚型为主。汉族HBV基因型以C基因型为主,且以C2亚型为主;维吾尔族HBV基因型以C基因型、C/D重组体为多,且以C1基因亚型为多。汉族C2基因型明显高于维吾尔族,而维吾尔族C/D重组体、D基因型明显高于汉族。在新疆地区,HBV基因型中依次为C基因型>C/D重组体>B基因型>D基因型;汉族基因型依次为C基因型>B基因型>C/D重组体>D基因型;维吾尔族基因型依次为C基因型>C/D重组体>D基因型>B基因型。C基因亚型汉族中C2亚型>C1亚型,维吾尔族中C1亚型>C2亚型。在乙肝肝硬化、肝癌中,C2所占亚型比例明显高于慢性乙型肝炎C2亚型的比例,有统计学意义(P<0.05),在肝癌中C2亚型明显高于C1亚型。
2)对新疆331份HBV感染的血清进行HBV PC、BCP变异研究结果显示,C1亚型BCP变异明显高于Ba亚型,PC变异在各亚型中无明显差别。Ba亚型BCP变异发生率最低,C/D重组体PC变异发生率最低。说明HBV不同的亚型之间存在PC、BCP变异的差异。维吾尔族HBV感染者C/D重组体的PC变异、BCP变异明显高于Ba亚型,差异有统计学意义(P<0.01)。C1亚型、C2亚型介于两者之间。在慢性乙型肝炎、乙肝肝硬化、肝癌中,HCC组的PC变异和BCP变异明显高于CH、LC组。
3)对新疆14例HBV感染的HBV全序测序,在新疆首次经过以上方法,首次报道出一种新的基因型,命名为C/D重组体。维吾尔族中的C/D重组体所占比例高于汉族C/D重组体的比例。,说明C/D重组体存在族别的差异。已在GenBank上注册。
4)对新疆18例P基因区变异位点进行分析。14例用阿德福韦治疗,13例出现变异,主要集中在聚合酶B区和D区附近。而且口服核苷类似物,随着时间的延长,出现HBV P基因变异的可能性增加;C1亚型变异主要集中在聚合酶B区附近,Ba亚型变异主要集中在聚合酶D区附近。YMDD变异的C2亚型比C1亚型的比例高,这方面的研究还需要更多实验证实。C1亚型变异主要集中在聚合酶B区附近,Ba亚型变异主要集中在聚合酶D区附近。
Hepatitis B Virus has a strong human pathogenicity in environment. It causes acute and chronic hepatitis, liver cirrhosis, and liver cancer.At the present stage, HBV infection is one of public health problem in China. HBV infection assumes cosmopolitism prevalence. It has distinct geographic distribution. There is highest prevalence of HBsAg (9.09%)in China. Incident rate and fatality of chronic hepatitis B, liver cirrhosis, liver cancer will be increased by it.
HBV has mutability and quasispecies characteristics. Now, HBV can be classified into at least eight genotypes (A-H) based on a divergence in the entire nucleotide sequence greater than 8% or S gene nucleotide sequence greater than4%, based on a divergence greater than 4% but less than 8% in the complete nucleotide sequence, HBV genotype has been divided into subgenotypes. HBV genotypes and subgenotypes have a distinct geographical distribution and a close relationship with ethnicity, as well as the relationship with clinical outcomes or responses to antiviral treatment. In China, genotype B and C are the most prevalent HBV strains.HBV showed different geographical distribution in our country, genotype C was predominant in northern China, genotype B was more prevalent in southern provinces. HBV mutation may appear with spontaneous, immunity and drug pressure. According to HBeAg, CHB was divided into HBeAg positive type and HBeAg negative type.PC and BCP mutations lead to HBeAg negative type on clinical manifestations.Long-term nucleoside analogue leads to HBV P genovariation.
Recently, HBV genotype has been studied in Xinjiang.There is HBV genotypes, subgenotype distinction between hans and Uygurs. The aim of this article is to study HBV molecular virology and clinical character deeply between hans and uighurs.
Object:
Xinjiang has its specificity, so it is necessary to study hans and Uygurs HBV molecular virology and clinical character. HBV genotype, subgenotype data will be analysed.PC and BCP regions of HBV genome mutation data and HBV P regions mutation data will be supplied. All of them will help to improve the level of prevention and treatment.
Contents:
1)To investigate the virological characteristics of these genotype, subgenotypes and their clinical characteristics in Xinjiang hans and Uygurs;
2) To investigate the virological features of the precore (PC) and basal core promoter (BCP) regions of the HBV genome and their clinical characteristics in Xinjiang Han and Uygurs;
3) To investigate the virological characteristics of P regions mutation of the HBV genome caused by nucleoside analogue antiviral treatment.
Method:
1) 331 HBV patients collected were from Xinjiang Province.A total of chronic hepatitis B patients with detectable HBV genotypes, subgenotype, PC and BCP regions were detected by PCR-restriction fragment length polymorphism (PCR-RFLP), a part of samples were validated by direct sequencing, nucleotide sequence analysis of the phylogenetic tree, bioinfomatic.
2)Randomized 14 samples has been dealed with by whole gene sequencing, 14 samples HBV P regions mutation caused by nucleoside analogue was assayed, 4 samples HBV P regions was assayed, sequence analysis of the phylogenetic tree, bioinfomatic.
Results:
Collect 331 HBV patients were from Xinjiang Province.A total of chronic hepatitis B patients were detected by PCR-RFLP, a part of samples validate by direct sequencing, nucleotide sequence analysis of the phylogenetic tree, bioinfomatic. 222 hans and 109 Uygurs, mean age±standard deviation, 38.7±12.7 years.
1) Amongst 331 HBV patients studied, HBV genotypes showed B genotype 12.7%, C genotype 64%, C/D recombinant 16%, D genotype 7.3%.Compare with Genotype B, Genotype C, recombinant C/ D and Genotype D, they showed the distinctly distribution in Han patients and Uighur patients.Further analysis showed that all genotype B strains belong to Ba subgenotype, Bj subgenotype was not found. Genotype C had two subgenotypes, C1 42.9%, C2 57.1% in Xinjiang. Han HBV genotype showed B 14.9%, C 72.9%, recombinant C/D 9.5%, D 2.7%, Uighur HBV genotype showed B 8.3%, C 45.9%, recombinant C/D 29.4%, D 16.5%. Han HBV subgenotype showed Ba 78.6%, C1 39.5%, C2 60.5% ; Uygurs Ba 21.4%, C1 54%, C2 46%?
2) Collect 331 HBV patients were from Xinjiang Province. HBV PC and BCP mutation of total chronic hepatitis B patients were detected by PCR-RFLP, a part of samples were validated by direct sequencing, nucleotide sequence analysis of the phylogenetic tree, bioinfomatic. HBV PC mutation showed PC mutation 30.2%, BCP mutation 34.4%.Further analysis showed C1 was associated with the highest tendency to develop BCP mutation. HBV recombinant C/D was associated with the highest tendency to develop BCP and PC mutation in Uygur.
3) 14 samples were defined that the complete HBV genome were sequenced and compared with HBV sequences retrieved from GenBank, representing HBV genotype A-G.. Entire nucleotide sequences revealed that 2 samples were recombinant C/D, 12 samples were genotyped D.Moreover, they had difference sequences. Entire nucleotide sequences of 14 samples were registered.
4) HBV P gene of 18 samples was sequenced and compared with HBV sequences retrieved from GenBank, representing HBV genotype A-G..Amongst 14 samples took adefovir, P gene mutation, the esults showed mutation nearby polymerase B(16) and D(6) appeared of 13 samples.Amongst C subgenotype, mutation nearby polymerase B(9) and D(1) with C1 was appeared in 5 samples, mutation nearby polymerase B(3) and D(3) with C2 was appeared in 5 samples, mutation nearby polymerase B(4) and D(8) with Ba was appeared in 6 samples, mutation nearby polymerase B(3) and D(1) with D was appeared in 1 samples, mutation nearby polymerase B(2) with C/D1 was appeared in 1 samples. Genotype B 11.8%, C 64.7%, C/D 20.6%, D 2.9% were showed in 34 YMDD mutation samples.
Conclusion:
1) Collect 331 HBV patients were from Xinjiang Province.A total of chronic hepatitis B patients were detected by PCR-RFLP, a part of samples validate by direct sequencing, nucleotide sequence analysis of the phylogenetic tree, bioinfomatic. The results showed that the most common HBV genotypes were C and subgenotype C2, while recombinant C/D was also found in Xinjiang. In Uygurs, the most common HBV genotypes were C, C/D and subgenotype C1.Genotype C/D and D have significantly different in Uygurs and Hans. HBV subgenotype C2 was a more important risk factor in hepatocarcinogenesis than other subgenotypes.
2) Collect 331 HBV patients were from Xinjiang Province. We studied HBV PC and BCP mutations. The result showed that the PC and BCP mutations have related with subgenotypes. Recombinant C/D has significantly different with Ba in Uygurs.
3) 14 samples were defined that the complete HBV genome were sequenced and compared with HBV sequences retrieved from GenBank, representing HBV genotype A-G.. Recombinant C/D was found by above method first time in Xinjiang Han and Uighur. They have been registered in GenBank.
4) 18 samples were defined that the HBV P gene was sequenced and compared with HBV sequences retrieved from GenBank, representing HBV genotype A-G..HBV patients with nucleoside analog(ue) has different mutation site in different subgenotype, concentrated nearby polymerase B and D.Uighur HBV patients has particularity in HBV P regions mutations.
HBV具有易变性及准种的特性。目前,根据HBV全基因组序列差异≥8%或S基因序列≥4%,将HBV分为A、B、C、D、E、F、G、H等8个基因型。HBV基因型有明确的地理和人种的分布特征。HBV在慢性感染过程中,变异可自发产生,也可在体内因宿主免疫压力或药物压力下而产生。如慢性乙型肝炎可因前C区变异和/或C区基因变异,不表达HBeAg而分为HBeAg阳性和HBeAg阴性两大类。HBV C基因基本核心基因启动子变异(BCP)和前C区变异(PC),可能与肝病严重程度有关。也具有一定的地域分布差别。HBV聚合酶有四个功能区,其中RT区有7个催化功能的基序,依次称为G、F、A、B、C、D、E区,其中,B、C、D区是P基因耐药变异最常见的部位。不同的核苷类似物耐药株的变异位点不同。
新疆是个多民族居聚区,HBV感染及疾病谱有其特殊性。研究表明,新疆维吾尔族HBV基因型以D基因型为多,与我国内地以B、C基因型为主的流行情况有所不同,为进一步证实新疆地区的不同民族HBV感染者的基因型分布特征,了解新疆不同民族的基因亚型的分布,前C区变异和C区变异,耐药变异等情况,为今后防治HBV奠定了理论的基础。目的:进一步证实新疆慢性HBV感染者的HBV基因型分布特征,了解新疆不同民族的基因亚型,PC、BCP变异及耐药变异的特征,为进一步研究防治HBV提供科学依据。尤其是研究新疆HBV感染者基因型、亚型分布有无特征。新疆HBV感染者的HBV PC变异和BCP变异与HBV感染病情严重性和HBeAg阴性有无关联性。了解P基因区变异与HBV不同基因型是否有联系以及抗病毒药物效果与P基因区变异之间的关系,旨在为今后防治HBV感染提供科学依据。
方法:
收集331例新疆慢性HBV感染者的血清,其中慢性乙型肝炎(CHB)240例,乙肝肝硬化(LC)64例,肝癌(HCC)27例。
1)采用聚合酶链反应限制性片段长度多态性(PCR-RFLP)方法,进行基因型、基因亚型、PC变异、BCP变异的检测,并对部分标本用直接测序法进行验证,所得的测序结果采用生物信息学技术进行分析比较。
2)对随机选择的14例标本进行全基因测序,选择14例用核苷类似物治疗的CHB及4例未用核苷类似物的标本进行P基因区测序,然后用生物信息学技术进行分析并与基因库进行比对分析。
结果:
1)用PCR-RFLP技术对新疆331例HBV感染者的HBV基因型、基因亚型进行检测,随机选取部分标本用直接测序法验证。结果显示331例慢性HBV感染者的HBV基因型为:B基因型12.7%,C基因型64%,C/D重组体16%,D基因型7.3%。进一步检测基因亚型显示B基因亚型均为Ba亚型,未检测到Bj亚型。在C基因型中,C1亚型42.9%,C2亚型57.1%。不同民族基因型分析显示,在汉族HBV感染者中,B基因型14.9%,C基因型72.9%,C/D重组体9.5%,D基因型2.7%,而维吾尔族HBV感染者中B基因型8.3%,C基因型45.9%,C/D重组体29.4%,D基因型16.5%。维吾尔族与汉族比较,基因型分布有差别(P<0.05)。进一步基因亚型结果显示Ba亚型中,汉族78.6%,维吾尔族21.4%。C基因亚型汉族76.4%,其中,C1亚型39.5%,C2亚型60.5%;而维吾尔族23.6%,C1亚型54%,C2亚型46%。在不同临床类型中,慢性乙型肝炎中,C1亚型26.7%,C2亚型33.3%。在乙肝肝硬化中,C1亚型30%,C2亚型45.3%。在肝癌中,C1亚型30.8%;C2亚型46.2%。
2)用PCR-RFLP技术检测HBV PC变异和BCP变异结果显示,PC变异30.2%,BCP变异34.4%。进一步比较PC变异和BCP变异,在不同亚型分布显示,Ba亚型中PC变异35.7%,BCP变异28.6%;C1亚型中PC变异37.4%,BCP变异41.8%;C2亚型PC变异25.6%,BCP变异31.4%;C/D重组体PC变异20.8%,BCP变异35.8%。C1亚型BCP变异明显高于Ba亚型,有统计学意义(P<0.05),PC变异在各亚型中无明显差别(P>0.05)。维吾尔族HBV感染者中,Ba亚型PC变异1.8%,BCP变异5.5%;C1亚型PC变异3.7%,BCP变异11%;C2亚型PC变异5.5%,BCP变异7.3%;C/D重组体PC变异6.4%,BCP变异12.8%,C/D重组体的PC变异、BCP变异明显高于Ba亚型,差异有统计学意义(P<0.01)。C1亚型、C2亚型介于两者之间。
3)使用PCR-RFLP技术对HBV PCR-测序方法,对14例病人进行全基因的测序。全基因测序证实2例C/D重组体,12例D基因型与RFLP方法保持一致。测序结果显示2例C/D重组体,12例D基因型与GenBank现有的序列有差异。全部在GenBank上收录。4)用PCR-测序方法,对新疆18例HBV感染者的HBV P基因区测序,采用
生物信息学技术进行分析,在P基因区变异结果显示,14例服用阿德福韦治疗,CHB标本中有13例出现P基因区变异。进一步分析显示,主要在聚合酶B区附近的变异(16个)和D区(6个)附近。
5例C1亚型在聚合酶B区附近的变异有9个;聚合酶D区附近的变异有1个。5例C2亚型在聚合酶B区附近的变异有3个;聚合酶D区附近的变异有3个。6例Ba亚型在聚合酶B区附近的变异有4个;聚合酶D区附近的变异有8个。1例D基因型在聚合酶B区附近的变异有3个;聚合酶D区附近的变异有1个。1例C/D1亚型在聚合酶B区附近的变异2个。34例YMDD变异中,B基因型11.8%,C基因型64.7%,C/D基因型20.6%例,D基因型2.9%,提示C基因型易出现YMDD耐药变异。在基因亚型中,10例C1亚型45.4%,12例C2亚型54.5%,YMDD变异在C2亚型比C1亚型的多。
结论:
1)新疆地区331例HBV感染者的HBV采用PCR-RFLP方法,部分标本测序验证,采用生物信息学技术进行分析,结果显示新疆HBV基因型以C基因型为主,且以C2亚型为主。汉族HBV基因型以C基因型为主,且以C2亚型为主;维吾尔族HBV基因型以C基因型、C/D重组体为多,且以C1基因亚型为多。汉族C2基因型明显高于维吾尔族,而维吾尔族C/D重组体、D基因型明显高于汉族。在新疆地区,HBV基因型中依次为C基因型>C/D重组体>B基因型>D基因型;汉族基因型依次为C基因型>B基因型>C/D重组体>D基因型;维吾尔族基因型依次为C基因型>C/D重组体>D基因型>B基因型。C基因亚型汉族中C2亚型>C1亚型,维吾尔族中C1亚型>C2亚型。在乙肝肝硬化、肝癌中,C2所占亚型比例明显高于慢性乙型肝炎C2亚型的比例,有统计学意义(P<0.05),在肝癌中C2亚型明显高于C1亚型。
2)对新疆331份HBV感染的血清进行HBV PC、BCP变异研究结果显示,C1亚型BCP变异明显高于Ba亚型,PC变异在各亚型中无明显差别。Ba亚型BCP变异发生率最低,C/D重组体PC变异发生率最低。说明HBV不同的亚型之间存在PC、BCP变异的差异。维吾尔族HBV感染者C/D重组体的PC变异、BCP变异明显高于Ba亚型,差异有统计学意义(P<0.01)。C1亚型、C2亚型介于两者之间。在慢性乙型肝炎、乙肝肝硬化、肝癌中,HCC组的PC变异和BCP变异明显高于CH、LC组。
3)对新疆14例HBV感染的HBV全序测序,在新疆首次经过以上方法,首次报道出一种新的基因型,命名为C/D重组体。维吾尔族中的C/D重组体所占比例高于汉族C/D重组体的比例。,说明C/D重组体存在族别的差异。已在GenBank上注册。
4)对新疆18例P基因区变异位点进行分析。14例用阿德福韦治疗,13例出现变异,主要集中在聚合酶B区和D区附近。而且口服核苷类似物,随着时间的延长,出现HBV P基因变异的可能性增加;C1亚型变异主要集中在聚合酶B区附近,Ba亚型变异主要集中在聚合酶D区附近。YMDD变异的C2亚型比C1亚型的比例高,这方面的研究还需要更多实验证实。C1亚型变异主要集中在聚合酶B区附近,Ba亚型变异主要集中在聚合酶D区附近。
Hepatitis B Virus has a strong human pathogenicity in environment. It causes acute and chronic hepatitis, liver cirrhosis, and liver cancer.At the present stage, HBV infection is one of public health problem in China. HBV infection assumes cosmopolitism prevalence. It has distinct geographic distribution. There is highest prevalence of HBsAg (9.09%)in China. Incident rate and fatality of chronic hepatitis B, liver cirrhosis, liver cancer will be increased by it.
HBV has mutability and quasispecies characteristics. Now, HBV can be classified into at least eight genotypes (A-H) based on a divergence in the entire nucleotide sequence greater than 8% or S gene nucleotide sequence greater than4%, based on a divergence greater than 4% but less than 8% in the complete nucleotide sequence, HBV genotype has been divided into subgenotypes. HBV genotypes and subgenotypes have a distinct geographical distribution and a close relationship with ethnicity, as well as the relationship with clinical outcomes or responses to antiviral treatment. In China, genotype B and C are the most prevalent HBV strains.HBV showed different geographical distribution in our country, genotype C was predominant in northern China, genotype B was more prevalent in southern provinces. HBV mutation may appear with spontaneous, immunity and drug pressure. According to HBeAg, CHB was divided into HBeAg positive type and HBeAg negative type.PC and BCP mutations lead to HBeAg negative type on clinical manifestations.Long-term nucleoside analogue leads to HBV P genovariation.
Recently, HBV genotype has been studied in Xinjiang.There is HBV genotypes, subgenotype distinction between hans and Uygurs. The aim of this article is to study HBV molecular virology and clinical character deeply between hans and uighurs.
Object:
Xinjiang has its specificity, so it is necessary to study hans and Uygurs HBV molecular virology and clinical character. HBV genotype, subgenotype data will be analysed.PC and BCP regions of HBV genome mutation data and HBV P regions mutation data will be supplied. All of them will help to improve the level of prevention and treatment.
Contents:
1)To investigate the virological characteristics of these genotype, subgenotypes and their clinical characteristics in Xinjiang hans and Uygurs;
2) To investigate the virological features of the precore (PC) and basal core promoter (BCP) regions of the HBV genome and their clinical characteristics in Xinjiang Han and Uygurs;
3) To investigate the virological characteristics of P regions mutation of the HBV genome caused by nucleoside analogue antiviral treatment.
Method:
1) 331 HBV patients collected were from Xinjiang Province.A total of chronic hepatitis B patients with detectable HBV genotypes, subgenotype, PC and BCP regions were detected by PCR-restriction fragment length polymorphism (PCR-RFLP), a part of samples were validated by direct sequencing, nucleotide sequence analysis of the phylogenetic tree, bioinfomatic.
2)Randomized 14 samples has been dealed with by whole gene sequencing, 14 samples HBV P regions mutation caused by nucleoside analogue was assayed, 4 samples HBV P regions was assayed, sequence analysis of the phylogenetic tree, bioinfomatic.
Results:
Collect 331 HBV patients were from Xinjiang Province.A total of chronic hepatitis B patients were detected by PCR-RFLP, a part of samples validate by direct sequencing, nucleotide sequence analysis of the phylogenetic tree, bioinfomatic. 222 hans and 109 Uygurs, mean age±standard deviation, 38.7±12.7 years.
1) Amongst 331 HBV patients studied, HBV genotypes showed B genotype 12.7%, C genotype 64%, C/D recombinant 16%, D genotype 7.3%.Compare with Genotype B, Genotype C, recombinant C/ D and Genotype D, they showed the distinctly distribution in Han patients and Uighur patients.Further analysis showed that all genotype B strains belong to Ba subgenotype, Bj subgenotype was not found. Genotype C had two subgenotypes, C1 42.9%, C2 57.1% in Xinjiang. Han HBV genotype showed B 14.9%, C 72.9%, recombinant C/D 9.5%, D 2.7%, Uighur HBV genotype showed B 8.3%, C 45.9%, recombinant C/D 29.4%, D 16.5%. Han HBV subgenotype showed Ba 78.6%, C1 39.5%, C2 60.5% ; Uygurs Ba 21.4%, C1 54%, C2 46%?
2) Collect 331 HBV patients were from Xinjiang Province. HBV PC and BCP mutation of total chronic hepatitis B patients were detected by PCR-RFLP, a part of samples were validated by direct sequencing, nucleotide sequence analysis of the phylogenetic tree, bioinfomatic. HBV PC mutation showed PC mutation 30.2%, BCP mutation 34.4%.Further analysis showed C1 was associated with the highest tendency to develop BCP mutation. HBV recombinant C/D was associated with the highest tendency to develop BCP and PC mutation in Uygur.
3) 14 samples were defined that the complete HBV genome were sequenced and compared with HBV sequences retrieved from GenBank, representing HBV genotype A-G.. Entire nucleotide sequences revealed that 2 samples were recombinant C/D, 12 samples were genotyped D.Moreover, they had difference sequences. Entire nucleotide sequences of 14 samples were registered.
4) HBV P gene of 18 samples was sequenced and compared with HBV sequences retrieved from GenBank, representing HBV genotype A-G..Amongst 14 samples took adefovir, P gene mutation, the esults showed mutation nearby polymerase B(16) and D(6) appeared of 13 samples.Amongst C subgenotype, mutation nearby polymerase B(9) and D(1) with C1 was appeared in 5 samples, mutation nearby polymerase B(3) and D(3) with C2 was appeared in 5 samples, mutation nearby polymerase B(4) and D(8) with Ba was appeared in 6 samples, mutation nearby polymerase B(3) and D(1) with D was appeared in 1 samples, mutation nearby polymerase B(2) with C/D1 was appeared in 1 samples. Genotype B 11.8%, C 64.7%, C/D 20.6%, D 2.9% were showed in 34 YMDD mutation samples.
Conclusion:
1) Collect 331 HBV patients were from Xinjiang Province.A total of chronic hepatitis B patients were detected by PCR-RFLP, a part of samples validate by direct sequencing, nucleotide sequence analysis of the phylogenetic tree, bioinfomatic. The results showed that the most common HBV genotypes were C and subgenotype C2, while recombinant C/D was also found in Xinjiang. In Uygurs, the most common HBV genotypes were C, C/D and subgenotype C1.Genotype C/D and D have significantly different in Uygurs and Hans. HBV subgenotype C2 was a more important risk factor in hepatocarcinogenesis than other subgenotypes.
2) Collect 331 HBV patients were from Xinjiang Province. We studied HBV PC and BCP mutations. The result showed that the PC and BCP mutations have related with subgenotypes. Recombinant C/D has significantly different with Ba in Uygurs.
3) 14 samples were defined that the complete HBV genome were sequenced and compared with HBV sequences retrieved from GenBank, representing HBV genotype A-G.. Recombinant C/D was found by above method first time in Xinjiang Han and Uighur. They have been registered in GenBank.
4) 18 samples were defined that the HBV P gene was sequenced and compared with HBV sequences retrieved from GenBank, representing HBV genotype A-G..HBV patients with nucleoside analog(ue) has different mutation site in different subgenotype, concentrated nearby polymerase B and D.Uighur HBV patients has particularity in HBV P regions mutations.
引文
[1] Lok AS,McMhaon BJ. Chronic hepatitis B[J]. HepatHepatology, 2001,34(6):1225-41.
[2]焦健.慢性乙型?丙型肝炎遗传易感性研究进展[J].国外医学免疫学分册,2004,225:148-51.
[3] World Health Organization. Hepatitis B. World Health Organization Fact Sheet 204 dex[M]. Revised October 2000.
[4]张申英,张欣欣,陆志檬. HLA复合体与乙型肝炎病毒感染的关系[J].国外医学病毒学分册,2000,7:107-11.
[5] McMahon BJ, Bulkow L, Harpster A et al. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B. a 16-year population-based study[J]. Hepatology, 2000,32:842-6.
[6] Ocama P, Opio CK, Lee WM. Hepatitis B virus infection:current status[J]. Am J Med,2005,118(12):14-13.
[7] Lok AS. Chronic hepatitis B[J]. N Engl J Med, 2002, 346(22):1682-3.
[8]庄辉.乙型肝炎流行病学研究进展[J].《国外医学:流行病学.传染病学分册》,2004,31(3):138.
[9] Jinlin Hou, Zhihua Liu, Fan Gu. Epidemiology and Prevention of Hepatitis B Virus Infection[J]. Int J Med Sci, 2005,2(1):50-57.
[10]梁晓峰,陈园生,王晓军,等.中国3岁以上人群乙型肝炎血清流行病学研究[J].中华流行病学杂志, 2005,26:655- 8?
[11]范金水,庄辉,李远贵,等.我国8城市HBsAg阳性和阴性乙型肝炎患者的病毒血清型和基因型分析[J].中华微生物学和免疫学杂志, 1998, 18:88-91.
[12]骆抗先乙型肝炎基础和临床[M].人民卫生出版社,第三版, 246.
[13] Has R, Yüksel A, Topuz S. Hepatitis B infection in pregnancy:is it really not harmful to the fetus? [J]. Prenat Diagn, 2001 ,21(8):701-2.
[14]孟钊,肖小敏,何明娇,等.乙肝病毒母婴垂直传播阻断的研究[J].实用妇产科杂志, 2005, 6:18-20.
[15]李端. HBV多样性与乙型肝炎传播途径的关系[J].国外医学(病毒学分册),2001,3.
[16]张宜俊,章谷生.乙型肝炎生物治疗[M].上海科学技术出版社, 2001:1-3.
[17]成军.乙型肝炎病毒基因组结构与功能复杂性的新认识[J].世界华人消化杂志, 2003,11(8):1073- 80.
[18]刘妍,成军,陆荫英,等.乙型肝炎病毒蛋白反式激活基因的研究[J].世界华人消化杂志, 2002,10:217-219.
[19]成军,朱传琳.肝炎病毒对双链RNA激酶PKR的调节作用[J].国外医学微生物学分册,2000,23:1-3.
[20] Lee JY, Locarnini S. Hepatitis B virus:pathogenesis, viral intermediates, and viral replication[J]. Clin Liver Dis, 2004,8:301- 20.
[21] Strader DB, Wright T, Thomas DL. et al. Diagnosis, managementand treatment of hepatitis C[J]. Hepatology, 2004, 39∶1147~ 71.
[22] Seeger C, Maso W. Hepatitis B virus biology[J]. Microbiol Mol Biol Rev, 2004, 64∶51~68.
[23] H. Guo, D. Jiang, T. Zhou, A. et al. Characterization of the Intracellular Deproteinized Relaxed Circular DNA of Hepatitis B Virus:an Intermediate of Covalently Closed Circular DNA Formation[J]. J. Virol., 2007,81(22):12472 - 84.
[24] Fabien Zoulim . Antiviral therapy of chronic hepatitis B:can we clear the virus and prevent drug resistance? [J].Antivir Chem Chemother, 2004,15(6):299-305.
[25] Augustine Chen, Y. F. Kao , Chris M. Brown. Translation of the first upstream ORF in the hepatitis B virus pregenomic RNA modulates translation at the core and polymerase initiation codons[J]. Nucleic Acids Research, 2005,33(4):1169- 81.
[26] Patrick Soussan, Florianne Garreau, Herve Zylberberg, et al. In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA[J]. J Clin Invest, 2000 ,105(1):55–60.
[27]董梅,张跃新.乙型肝炎病毒基因型的分布及临床意义[J].中华肝脏病杂志, 2005, 13(1):56-57 .
[28]夏国良, Omana V,贾志远,等.单纯乙型肝炎疫苗免疫后携带者表面抗原氨基酸置换的频率和特征[J].中华实验和临床病学杂志, 2001, 15:212- 15.
[29]闫伯英,胡志东.乙型肝炎病毒变异的临床研究进展[J].国际病毒学杂志, 2006, 13(1):29- 32.
[30] Hu KQ. Occult hepatitis B virus infection and its clinical implica tions[J]. J Viral Hepat, 2002, 9:243-57.
[31] Wallace LA, Carman WF. Surface gene variant of HBV:scientific and medical relevance[J]. Vir Hep Revs, 1997, 3:5 -16.
[32] Tang JH, Yeh CT, Chen TC, et al Emergence of an S gene mutant during thymosin alpha-1 therapy in a patient with chronic hepatitis B[J]. J Infect Dis ,1998, 178:866-8 69.
[33] Carman WF, Frederick J, Van deursen1 The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia1[J]. Hepatology, 1997, 26:16582- 661.
[34] Carman WF, Korula J, Wallace LA1. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA[J]. Lancet, 1995, 345:14062- 071.
[35] H. E. Kohrt,D. L. Ouyang,E. B. Keeffe.Lamivudine Prophylaxis for Chemotherapy-Induced Reactivation of Chronic Hepatitis B Virus [J]. Infection Aliment Pharmacol Ther,2006,24(7):1003- 16.
[36] Chong Jin Oon, Shiuan Koh Horizontal .Transmission of a Hepatitis B Virus Surface Antigen Mutant [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000,38(2):938– 9 ..
[37] Hou J, Wang Z, Cheng J, et al. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface[J] .World J Gastroenterol ,2005,11(13):2004- 8.
[38] Hong-Zhi Yang, Jian-An Zhao, Min Dai, et al. Traditional Chinese medicine syndromes of chronic hepatitis B with precore mutant antigen-negative Chinese carriers[J]. Hepatology, 2001,34(5):1027-34.
[39] Davaalkham, T. Ojima, R. Uehara et al. Analysis of hepatitis B surface antigen mutations in Mongolia:Molecular epidemiology and implications for mass vaccination_D[J]. Arch Virol, 2007, 152:575–84.
[40] H Okamoto, F Tsuda, Y Akahane, et al .Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen[J]. J Virol, 1994, 68(12):8102–10.
[41]高学松,成军,甄真,等.乙型肝炎核心启动子的研究进展[J].世界华人消化杂志, 2005, 13(8):933-6.
[42] HAMATAKE Robert K, LAU Johnson Y.N. Hepatitis B and D protocols, Volume 1 : detection, genotypes and characterization , (Methods in molecular medicine, Vol. 95) [M] 2004,2.
[43] Lieven Stuyver, Sija De Gendt, Caroline Van Geyt . A new genotype of hepatitis B virus:complete genome and phylogenetic relatedness[J]. Journal of General Virology , 2000,81:67-74.
[44] Henry Lik-Yuen Chan, Woon-Choi Tsang, Chook-Tiew Liew. Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage inHBeAg-negative chronic hepatitis B virus infection[J] .The American Journal of Gastroenterology, 2002,97(2):406-12.
[45] Cheng Y, Seet BL, Ong CS, et al. Are in vitro hepatitis B core promoter mutations important for clinical alterations in viral load ? [J].Antiviral Res, 2006, 69(3):142- 51.
[46] Buti M, Rodriguez- Frias F, Jardi R. Hepatitis B virus genome variability and disease progression:the impact of pre-core mutants and HBV genotypes[J]. J Clin Virol,2005, 34(Suppl 1):S79-82.
[47] Le Pogam S, Yuan TT, Sahu G, et al. Low-level secretion of human hepatitis B virus virions caused by two independent, naturallyoccurring mutations(P5T and L60V)in the capsid protein[J]. J Virol, 2000,74(19):9099-105.
[48]朱佳莉,张欣欣.乙型肝炎病毒复制特点及其重要基因变异[J]. Inter J Epidemiol Infect Dis, 2006,33(8):4251-4.
[49] Kuang SY, Jackson PE, Wang JB, et al. Specific mutations of hepatitis B Kuang SY, virus in plasma predict liver cancer development[J]. J.PNAS, 2004,101(10):3575- 80.
[50] Scaglioni PP, Melegari M, Wands JR. Biologic properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame[J]. Virology, 1997, 233:374-81.
[51] Locarnini S, Shaw T, Dean J, et al. Cellular response to conditional expression of the hepatitis B virus precore and core proteins in cultured hepatoma(Huh-7)cells. J Clin Virol.2005;32(2):113- 21.
[52] Hiroshi Y Elichi T Elichi T. Precore and core promoter mutations hepatitis B virus DNA levels and progressive liver injury in chronic hepatitis B[J]. HEPATOLOGY, 2002,37:355- 63.
[53] Lindh M, Andersson AS, Gusdal A. Genotypes, nt1858 variants, and geographiorigin of hepatitis B virus-large scale analysis using a new genotyping method[J]. J Infect Dis, 1997,175:1285- 93.
[54] Bartholomew MM, Jeffers L.J.Hepatitis B virus resistence to lamivudine given for recurrent infection atter orthotopic liver transplantation[J]. LANCET, 1997,349:20- 22 .
[55] Sadakazu Usuda, Hiroaki Okamoto, Hiroko Iwanari et al .Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product. Immunology[J]. Journal of VirologicalMethods.1999,80(1):97-112.
[56] Lai CL, Dienstag J, Schiff E, et al. Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B[J]. Clin Infect Dis,2003,36:687-96.
[57] Lai CL, Dienstag J, Schiff E, et al. Prevalence and clinical corre2 lates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B[J]. Clin Infect Dis,2003,36:687-96.
[58]熊笑风.乙型肝炎病毒耐药性研究进展[ J].肝脏杂志.2006;11(4):273- 5.
[59] Stuyver LJ, Locarnini SA, Lok A, et al. Nonenclature for antiviral–resistant human hepatitis B virus mutations in the polymerase region[J]. Hepatology, 2001,33(3):751- 7.
[60] WRIGHT T L. Clinical trail results and treatment resistance with Lamivudine in hepatitis B[J] . Seminars liver disease , 2004, 24: 31-36.
[61]许东,田德英,王卫华,等.乙型肝炎病毒YMDD及e抗原相关多重变异及临床意义[J].中华内科杂志,2004,43(2):121-4.
[62] Stuyver LJ, Locarnini SA, Lok A, et al. Nomenclature for antiviralresistant human hepatitis B virus mutations in the polymerase region[J]. Hepatology, 2001,33(3): 751-7.
[63] Delaney WE 4th, Locarnini S, Shaw T. Resistance of hepatitis B virus to antiviral drugs:current aspects and directions for future investigation[J]. Antivir Chem Chemother, 2001,12(1):1-35.
[64] Zollner B, Petersen J, Puchhammer-Stockl E, et al. Viral features of lamivudine resistant hepatitis B genotypes A and D[J]. Hepatology,2004,39(1):42-50.
[65] Akuta N, Suzuki F, Kobayashi M,et al. The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment[J]. J Hepatol , 2003,38:315-21.
[66] Delan ey We4th, Yang H, Westland CE, et al. The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro[J]. J Virol,2003, 77(21):11833- 41.
[67] Angus P, Vaughan R, Xiong S, et al. Resistance to adefovir dipivoxil therapy associated with development of a novel mutation in the HBV polymerase[J]. Gastroenterology,2003,125(2):292-7.
[68] Bartholomeusz A, Locarnini S, Ayres A, et al. Molecular modelling of hepatitis B virus polymerase and adefovir resistance identifies three clusters of mutations[J].Hepatology, 2004,40:246 .
[69]张欣欣.乙型肝炎病毒耐药突变产生的分子病毒学机制[J].肝脏杂志, 2006, 11[增刊]:1- 4.
[70] Tenney DJ, Levine SM, Rose RE, et al. Clinical emergence of entecavir- resistant hepatitis B virus requires additional substitutions in virus already resistant to lamivudine[J]. Antimicrob Agents Chemother,2004, 48(9):3498-507.
[71] Pawlotsky JM. The concept of hepatitis B virus mutant escape[J]. J Clin Virol,2005, 34(Suppl 1):125-9.
[72] Colonno R, Rose R, Levine S, et al. Entecavir two year resistance update:no resistance observed in nucleoside naive patients and low frequency resistance emergence in lamivudine refractory patients[J]. J. Hepatology,2005, 42(1):267.
[73] Alexandra Valsamakis. Molecular Testing in the Diagnosis and Management of Chronic Hepatitis B [J].J CLINICAL MICROBIOLOGY REVIEWS,2007, 7:426-39.
[74] Okamoto H, Tsuda F, Sakugawa H, et al. Typing hepatitis B virus by homology in nucleotide sequence:comparison of surface antigen subtypes[J]. J Gen Virol, 1988, 69:2575-83.
[75] Stuyver L, DeGendt S, VanGeyt C, et al. . A new genotype of hepatitis B virus:complete genome and phylogenetic relatedness[J]. J Gen Virol,2000, 81:67-74.
[76] Arauz-Ruiz P, Norder H, Robertson BH, et al. Genotype H:a new Amerindian genotype of hepatitis B virus revealed in Central America[J]. J Gen Virol,2002, 83:2059-73.
[77] Tsubota A, Arase Y, Ren F, et al. Genotype may correlate with liver carcinogenesis and tumor characteristics in cirrhotic patients infected with hepatitis B virus subtype adw[J]. J Med Virol,2001, 65:257-65.
[78]杨夏,张跃新,朱滨等. HBV基因型芯片检测方法的研究[J].中华微生物学和免疫学杂志, 2005,25:603.
[79] G. Zeng, Z. Wang, S. Wen et al. Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China[J]. Journal of Viral Hepatitis, 2005, 12(6):609-17.
[80] Chan HL, Leung NW, Hussain M, et al. Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong[J]. Hepatology, 2000, 31:763- 8.
[81] Arauz-Ruiz P, Norder H, Robertson BH, et al. Genotype H:a new Amerindiangenotype of hepatitis B virus revealed in Central America[J]. J Gen Virol,.2002, 83:2059-73.
[82] Sumi H, Yokosuka O, Seki N,et al. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease[J]. Hepatology, 2003,37:19-26.
[83] Chan HL, Tsang SW, Liew CT, et al. Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection[J]. Am J Gastroenterol, 2002, 97:406-12.
[84] Ding X, Mizokami M, Ge X, et al. Different hepatitis B virus genotype distributions among asymptomatic carriers and patients with liver diseases in Nannning, southern China[J]. Hepatol Res,2002, 22:37-44.
[85]许军,王齐欣,蒋栋,等.乙型肝炎病毒基因型与病情轻重的关系[J].中华肝脏病杂志,2003, 11:11-13.
[86]李卓,李洪权,李俊红,等.北京地区乙型肝炎病毒基因型与其感染临床表型的相关性[J].世界华人消化杂志, 2005, 13(24):2823-27.
[87] Huy TT, Ushijima H, Win KM, et al. High p revalence of hepatitis B virus p re2smutant in countrieswhere it is endemic and its relationship with genotype and chronicity [J] . J Clin Microbiol, 2003, 41:5449-55.
[88] Duong TN, Horiike N, Michitaka K, et al. Comparison of genotypes C and D of the hepatitisB virus in Japan:a clinical and molecular biological study [J] . J Med Virol, 2004, 72:551-7.
[89] Mayerat C, Mantegani A, Frei PC. Does hepatitis B virus(HBV)genotype influence the clinical outcome of HBV infection[J]. J Viral Hepat,1999, 6:299-304.
[90]沈建坤,周荣,王战会,等.实时荧光聚合酶链反应检测HBV基因型B~D方法的建立[J] .第一军医大学学报, 2005, 25:630-2.
[91] Yotsuyanagi H, Okuse C, Yasuda K, et al. Distinct geographic distributions of hepatitis B virus genotypes in patients with acute infection in Japan[J]. J Med Virol,2005, 77:392-46.
[92] Kao JH, Wu NH, Chen PJ, et al. HepatitisB genotypes and the response to interferon therapy [J]. J Hepatol,2001, 35:829-30.
[93] Sakai T, Shiraki K, Inoue H, et al. Efficacy of long-term interferon therapy in chronic hepatitis B patientswith HBV geno-type C [J] . Int J MolMed,2002, 10:201-4.
[94]周建良,吴诗品.拉米呋啶治疗乙型肝炎病毒B?C基因型疗效比较[J].中华肝脏病杂志, 2004, 12:489-90.
[95]刘兴,唐红,何芳.乙型肝炎病毒基因型研究新进展[J].世界华人消化杂志. 2006, 22:17-9.
[96] Wang, Z. Hou, J. Zeng, G. et al. Distribution and characteristics of hepatitis B virus genotype C subgenotypes in China[J]. Journal of Viral Hepatitis,2007, 14(6):426-34.
[97] Wang Z, Huang Y, Wen S, et al. Hepatitis B virus genotypes and subgenotypes in China[J]. Hepatol Res, 2007,37(1):36-41.
[98] Cui C, Shi J, Hui L, et al. The dominant hepatitis B virus genotype identified in Tibet is a C/D hybrid[J]. J Gen Virol, 2002,83(11):2773-7.
[99] Tseng TC, Liu CJ, Chen PJ,et al. Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan[J]. Liver Int, 2007,27(7):983-8.
[100] Zeng GB, Wen SJ, Wang ZH. A novel hepatitis B virus genotyping system by using restriction fragment length polymorphism patterns of S gene amplicons [J].World J Gastroenterol, 2004,10(21):3132- 6.
[101] Sugauchi F, Kumada H, Sakugawa H, et al. Two subtypes of genotype B(Ba and Bj)of hepatitis B virus in Japan[J]. Clin Infect Dis, 2004,38(9):1222-8.
[102] Tanaka, Y., M. Mukaide, E. Orito, et al. Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma[J]. J. Hepatol,2006, 45:646-53.
[103]房继莲,魏来,李若冰,等. INNO2LiPA乙型肝炎病毒基因分型方法的评价[J].中华检验医学杂志,2004, 27(12):846-8.
[104] Bartholomeusz, A., Schaefer S. Hepatitis B virus genotypes:comparison of genotyping methods[J]. Rev. Med. Virol,2004, 14:3-16.
[105] Usuda S, Okamoto H, Tanaka T, et al. Differentiation of hepatitis B virus genotypes D and E by ELISA using monoclonal antibodies to epitopes on the preS2-region product[J]. Journal of virological methods, 2000, 87(2):81-89.
[106] Sugauchi F, Orito E, Ichida T, et al. Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C[J]. Gastroenterology, 2003, 124:925-32.
[107] Huy TT, Ushijima H, Quang VX, et al. Genotype C of hepatitis B virus can be classified into at least two subgroups[J]. J Gen Virol , 2004,85:283-92.
[108] Chu CJ, Keeffe EB, Han SH, et al. Hepatitis B virus genotypes in the United States:results of a nationwide study[J]. Gastroenterology, 2003, 125(2):444-51.
[109] Luo K, Liu Z, He H. et al. The putative recombination of hepatitis B virus genotype B with pre-c/c region of genotype C[J]. Virus Genes, 2004,29:31-41.
[110]鲁晓擘,王晓岚,邓国宏,等.新疆维吾尔族慢性乙型肝炎患者HBV基因型分布及其特点[J].中华肝脏病杂志, 2007, 15(4):241-244.
[111] Bollyky PL, Harvey PH. Recombination between sequences of hepatitis B virus from different genotypes[J].Journal of Molecular Evolution, 1996, 42:97-102.
[112] Bowyer, S. M. and Sim, J. G.(2000):Relationships within and between genotypes of hepatitis B virus at points across the genome:footprints of recombination in certain isolates[J]. J. Gen. Virol., 81, 379- 92.
[113] Huy Thien-Tuan Tran, Hiroshi Ushijima, Trinh Thi Ngoc, et al. Recombination of Genotypes B and C in Hepatitis B Virus Isolated from a Vietnamese Patient with Fulminant Hepatitis[J]. Jpn. J. Infect. Dis,2003, 56(1):35-37.
[114] Yano Y, Truong BX, Seo Y, et al. Japanese case of hepatitis B virus genotypes C/D hybrid[J]. Hepatol Res, 2007, 37(12):1095-9.
[115] Sugauchi F, Orito E, Ichida T, et al. Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C[J]. Gastroenterology, 2003 ,12(4):925-32.
[116] Yuen MF, Sablon E, Tanaka Y, et al. Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong Kong[J]. J Hepatol, 2004, 41:119-25.
[117]温志立,谭德明.多对型特异性引物巢式PCR检测湖南省乙肝病毒基因型[J].世界华人消化杂志, 2004,12:332-5.
[118] Liu CJ, Chen BF, Chen PJ .Role of viral factors in the natural course and therapy of chronic hepatitis B[J] .Hepatology International, 2007, 12(1):415-30.
[119] Chan, H. L. Y., Tsui, S. K. W., Tse Chi Hang. Epidemiological and virological characteristics of 2 subgroups of hepatitis B virus genotype C[J]. Journal of Infectious Diseases, 2005, 191(12):2022-32.
[120] Hou J, Lau GK, Cheng J et al. T1762/A1764 variants of the basal core promoter of hepatitis B virus;serological and clinical correlations in Chinese patients[J]. Liver, 1999,19(5):411-7.
[121] Liu C J, K aoJ H, L aiM Y, et a l. P recore/corep romoterm utationsa ndgen otypeso fh epatitisB virusin c hronich epatitisB patients withful mi nan to rsu bfulminanth epatitis[J]. J M edV irol, 2004,72(4):545-50.
[122] Ling R, Mutimer D, Ahmed M, et al. Selection of mutations in the hepatitis B viruspolymerase during therapy of transplant recipients with lamivudine[J]. Hepatology, 1996, 24:711- 13.
[123] Tipples GA, Ma MM, Fischer KP. et al. Mutation in HBV RNA dependent DNA polymerase confers resistance to lamivudine in vivo[J]. Hepatology, 1996, 24:714-7.
[124] Kobayashi S, Ide T, Sata M. Detection of YMDD motif mutations in some lamivudine untreated asymptomatic hepatitis B virus carriers[J]. J Hepatol, 2001, 34:584-6.
[125]霍红,赵书民,蔡雄,等. YMDD自然变异毒株流行病学调查[J].肝脏, 2006, 4:232-4.
[126] Stuyver LJ, Locarnini SA, Lok A, et al. Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region[J]. Hepatology,2001,33:751–7.
[127] Bozdayi AM, Uzunalimoglu O, Turkyilmaz AR, et al. YSDD:a novel mutation in HBV DNA polymerase confers clinical resistance to lamivudine[J]. J Viral Hepat,2003,10(4):256-65.
[128] Bock CT, Tillmann H, Torresi J, et al. Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplanta- tion[J]. Gastroenterology, 2002, 122(2);264-73.
[129] Torresi J, Earnest-Silveira L, Deliyannis G, et al. Reduced Antigenicity of the Hepatitis B Virus HBsAg Protein Arising as a Consequence of Sequence Changes in the Overlapping Polymerase Gene That Are Selected by Lamivudine Therapy[J]. Virology ,2002, 293(2):305-13.
[130] Torresi J. The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus[J]. J Clin Virol, 2002,25(2):97- 106.
[131] Angus P, Vaughan R, Xiong S, et al. Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase[J]. J Gastroenterology, 2003, 125(2):292-7.
[132] Lin X, Yuan ZH, Wu L, et al. A single amino acid in the reverse transcriptase domain of hepatitis B virus affects virus replication efficiency[J]. J Virol,2001, 75(23):11827-33.
[133] Kao JH, Liu CJ, Chen DS. Hepatitis B viral genotypes and lamivudine resistance[J]. J Hepatol, 2002, 36:303– 4.
[1]董梅,张跃新.乙型肝炎病毒基因型的分布及临床意义[J].中华肝脏病杂志, 2005, 13:56-57 .
[2]李雅娟,庄辉.乙型肝炎病毒基因亚型研究进展[J].传染病信息, 2005,18(4):176.
[3]徐红,张跃新,魏来,等.新疆汉族人群HBV基因型与临床病情的关系[J].实用肝脏病杂志, 2005,8(1):11-15.
[4]徐红张跃新肖琳等新疆地区汉族人群乙型肝炎病毒基因型的分布及其与临床类型的关系[J].中华肝脏病杂志, 2005, 13(11):848-9.
[5] Miyakawa Y, Mizokami M. Classifying hepatitis B virus genotypes[J]. Intervirology ,2003,46:329-38.
[6] Norder H, Courouc AM, Coursaget P, et al. Genetic diversity of hepatitis B virus strains derived worldwide:genotypes, subgenotypes, and HBsAg subtypes[J]. Intervirology, 2004, 47:289-309.
[7] Bowyer, S.M. and Sim, J.G.Relationships within and between genotypes of hepatitis B virus at points across the genome:footprints of recombination in certain isolates[J]. Gen. Virol,2000, 81: 379-92.
[8] Bartholomeusz A, Schaefer S. Hepatitis B Virus Genotypes:Comparison of genotyping methods[J] . Reviews in Medical Virology. Bartholomeusz A, 2004, 14:3-16.
[9] Hou J, Liu Z, Gu F. Epidemiology and prevention of hepatitis B virus infection[J] . Int J Med Sci ,2005, 2(1):50-57.
[10] Miyakawa Y, Mizokami M. Classifying hepatitis B virus genotypes[J]. Intervirology, 2003, 46:329-38.
[11] Alexandra Valsamakis.Molecular Testing in the Diagnosis and Management of Chronic Hepatitis B[J]. J CLINICAL MICROBIOLOGY REVIEWS 2007, 7:426-39.
[12] Moskovitz DN, Osiowy C, Giles E et al.Response to long-term lamivudine treatment(up to 5 years)in patients with severe chronic hepatitis B, role of genotype and drug resistance[J]. Journal of Viral Hepatitis. Moskovitz DN Giles E Giles E, 2005, 12(4):398-404.
[13] Yuen MF, Yuan HJ, Yuan HJ et al. Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, andhepatocellular[J]. Hepatology, 2003, 37:562-7.
[14] Yuen MF, Sablon E, Tanaka Y, et al.Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong Kong[J].J Hepatol, 2004, 41:119-125.
[15] Jazayeri MS, Basuni AA, Cooksley G, et al.Hepatitis B virus genotypes, core gene variability and ethnicity in the Pacific region[J].J Hepatol,2004, 41:139-146.
[16] Kato H, Orito E, Gish RG, et al.Characteristics of hepatitis B virus isolates of genotype G and their phylogenetic differences from the other six genotypes(A through F) [J].J Virol ,.2002, 76:6131-7.
[17] Kramvis A, Weitzmann L, Owiredu WK, et al. Analysis of the complete genome of subgroup A' hepatitis B virus isolates from South Africa[J]. J Gen Virol ,2002, 83:835-9.
[18] Kimbi GC, Kew MC, Kew MC et al.Distinctive sequence characteristics of subgenotype A1 isolates of hepatitis B virus from South Africa[J]. J Gen Virol, 2004, 85(5):1211-20.
[19] Chan HL, Leung NW, Hussain M, et al.Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong[J].Hepatology, 2000, 31:763-8.
[20] Tsubota A, Arase Y, Ren FT.Genotype may correlate with liver carcinogenesis and tumor characteristics in cirrhotic patients infected with hepatitis B virus subtype adw[J].J Med Virol, 2001, 65:257-65.
[21] Arauz-Ruiz P, Norder H, Robertson BH, et al.Genotype H:a new Amerindian genotype of hepatitis B virus revealed in Central America[J].J Gen Virol, 2002, 83:2059-73.
[22] Ding X, Mizokami M, Ge X, et al.Different hepatitis B virus genotype distributions among asymptomatic carriers and patients with liver diseases in Nannning, southern China[J]..Hepatol Res, 2002, 22:37-44.
[23]许军,王齐欣,蒋栋,等.乙型肝炎病毒基因型与病情轻重的关系[J]..中华肝脏病杂志, 2003, 11:11-13.
[24] Wai CT, Fontana RJ, Polson J, et al.Clinical significance of hepatitis B virus genotypes, variants, and mutants[J].Clin liver dis,2004, 8(2):321-52, vi .
[25] Lindh M, Hannoun c, dhillon AP, et al.Core promoter mutations and genotypes in relation to viral replication and liver damage in East asian hepatitis B virus carriers[J].J infect Dis,1999, 179(4):775-82
[26] Magnius LO, Norder H.Subtypes, genotypes and molecular epidemiology of thehepatitis b virus as reflected by sequence variability of the S-gene[J]. Intervirology, 1995, 38(1-2):24-34.
[27] Bartholomeusz A, Schaefer S.Hepatitis B virus genotypes:comparison of genotyping methods[J]. Rev Med Virol,2004, 14(1):3-16.
[28] Huy TT.Ushijima H, Quang VX, et al.Genotype C of hepatitis B virus can be classified into at least two subgroups[J].J Gen Virol,2004, 85(2):283-92.
[29] Kurbanov F, Tanaka Y, Fujiwara K, et al. A new subtype(subgenotype)Ac(A3)of hepatitis B virus and recombination between genotypes A and E in Cameroon[J]. J Gen Virol, 2005, 86:2047-56.
[30] Sugauchi F, Kumada H, Sakugawa H, et al. Two subtypes of genotype B(Ba and Bj)of hepatitis B virus in Japan[J]. Clin Infectious Dis, 2004, 38:1222-8.
[31] Norder H, Courouce AM, Coursaget P, et al . Genetic diversity of hepatitis B virus strains derived worldwide:Genotypes, subgenotypes and HBsAg subtypes[J]. Intervirology ,2004, 47:289-309.
[32] Sugauchi F, Orito E, Ichida T, et al . Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene[J]. J Virol, 2002, 76:5985-92.
[33] Norder H, Courouce AM, Coursaget P, et al . Genetic diversity of hepatitis B virus strains derived worldwide:Genotypes, subgenotypes and HBsAg subtypes[J]. Intervirology, 2004, 47:289-309.
[34] Chan HL, Tsui SK, Tse CH, et al . Epidemiological and virological characteristics of 2 subgroups of hepatitis B virus genotype C[J]. J Infect Dis, 2005, 191:2022-32.
[35] Huy TT, Quang VX. Genotype C of hepatitis B virus can be classified into at least two subgroups[J] .Journal of General Virology, 2004, 85(2):283- 92.
[36] Helene Norder, Anne-Marie Couroucé, Pierre Coursaget, et al Genetic Diversity of Hepatitis B Virus Strains Derived Worldwide:Genotypes, Subgenotypes, and HBsAg Subtypes[J]. Intervirology ,2004, 47:289-309.
[37] Fuat Kurbanov, Yasuhito Tanaka, Kei Fujiwara, et al.A new subtype(subgenotype) Ac(A3) of hepatitis B virus and recombination between genotypes A and E in Cameroon[J]. J Gen Virol,2005, 86:2047- 56.
[38] Lindh M, Andersson AS, Gusdal A.Genotypes, nt1858 variants and geographic origin of hepatitis B virus-large-scale analysis using a new genotyping method[J].J Infect Dis, 1997, 175(6):1285-93.
[39] Lindh M, Gonzalez JE, Norkrans G et al.Genotyping of hepatitis B virus byrestriction pattern analysis of a pre-s amplicon[J]. J Virol methods,1998, 72(2):163-74.
[40] Mizokami M, Nakano T, Orito E et al.Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns[J].FEBSLett, 1999,450(1-2):66- 71.
[41] Zeng GB, Wen SJ, Wang ZH, et al.A novel hepatitis B virus genotyping system by using restriction fragment length polymorphism patterns of S gene amplicons[J]. World J Gastroenterol,2004, 10(21):3132-6.
[42] Hasegawa I, Kramvis A.Novel hepatitis B virus genotype a subtyping assay that distinguishes subtype Aa from Ae and its application in epidemiological studies[J].Journal of Virology. 2004, 78:7575- 81.
[43] Tanaka Y, Hasegawa I, Kato T,et al.A case-control study for differences among hepatitis B virus infections of genotypes A(subtypes Aa and Ae)and D[J].J Hepatology, 2004, 40(3):747-55.
[44] Nakayoshi, T., Maeshiro, T., Nakasone, H. et al.. Difference in prognosis between patients infected with hepatitis B virus with genotype B and those with genotype C in the Okinawa Islands: a prospective study[J]. Journal of Medical Virology, 2003,70: 350–4.
[45] Arauz-Ruiz, P., Norder, H., Robertson, B. H. et al.. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America[J]. Journal of General Virology, 2002,83:2059–73.
[46] Huy, T, Ushijima, H, Quang, V. X., et al. Genotype C of hepatitis B virus can be classified into at least two subgroups[J]. J. Gen. Virol,2004, 85:283-92.
[47] Norder H, Hammas B, Lofdahl S, et al.Comparison of the amino acid sequence of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains[J].J Gen Virol, 1992, 73(5):1201-8.
[48] Naito H, Hayashi S, Abe K.Rapid and specific genotyping system for hepatitis B virus corresponding to six major genotypes by PCR using typespecific primers[J].J Clin Microbiol, 2001, 39(1):362-4.
[49] Kirschberg O, Repp R, et al. A Multiplex-PC R to Identify Hepatitis B Virus-genotypes A-F[J]. J Clin Virol,2004, 29:39-43..
[50] Hasegawa I, Tanaka Y, Kramvis A .Novel hepatitis B virus genotype a subtyping assay that distinguishes subtype Aa from Ae and its application in epidemiological studies[J] .Journal of Virology, 2004, 78:7575-81.
[51] Andreasson H, Asp A, A1derborn A, et al. Mitochondrial sequence analysis for forensic identification using pyrosequencing technology[J].Biotechniques, 2002, 32(1):124-6.
[52]房继莲魏来李若冰等. INNO2LiPA乙型肝炎病毒基因分型方法的评价[J].中华检验医学杂志,.2004, 27(12):846-8.
[53] Sija De Gendt, Fred Shapiro, Jelena Juras, et al.Hepatitis B Viral Genotyping with the Research INNO-LiPA HBV Genotyping Line Probe Assay[J]. Infectious Diseases J ,2004, 28(1):175-186 .
[54] Grandjacques C, pradat P, stuyver L, et al.Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome:correlation with viral persistence and disease severity[J].J hepatol,2000, 33(3):430-9.
[55]王小红,何忠平,庄辉等.乙型肝炎病毒聚合酶链反应基因分型法的建立及应用[J].中华肝脏病杂志,2003, 5:35-9
[56] Wai CT, Fontana RJ.clinical significance of hepatitis B virus genotypes, variants, and mutants[J].clin Liver Dis,2004;8(2):321-52.
[57] Hussain M, Chu CJ, sablon E, et al.Rapid and sensitive assays for determination of hepatitis B virus(HBV)genotypes and detection of HBV precore and core promoter variants[J].J Clin Microbiol,2003, 41(8):3699-705.
[58] Osiowy C, Giles E.Evaluation of the INNO-LiPA HBV genotyping assay for determination of hepatitis B virus genotype[J].J Clin Microbiol, 2003,41(12): 5473-7.
[59] Bartholomeusz, A., and Schaefer S.Hepatitis B virus genotypes:comparison of genotyping methods[J].Rev.Med.Virol,2004, 14:3-16.
[60] Usuda S, Okamoto H, Tanaka T, et al., Differentiation of hepatitis B virus genotypes D and E by ELISA using monoclonal antibodies to epitopes on the preS2-region product[J].Journal of virological methods ,2000, 87(2):81-89.
[61] Usuda S, Okamoto H, Iwanari H, et al.Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product[J].J Virol Methods,1999, 80(1):97-112.
[62] Kato H, Orito E, sugauchi F, et al.Determination of hepatitis B virus genotype G by polymerase chain reaction with hemi-nested primers[J].J Virol Methods,2001, 98(2):153-64
[63] Moriya T, Kuramoto IK, Yoshizawa H, et al.Distribution of hepatitis B virusgenotypes among American blood donors determined with a PreS2 epitope enzyme-linked immunosorbent assay kit[J].J Clin Microbiol,2002, 40(3):877-80.
[64] Luo K, Liu Z, He H, et al.The putative recombination of hepatitis B virus genotype B with pre-C/C region of genotype C[J].Virus genes,2004, 29(1):31-41.
[65]杨夏,张跃新,朱滨等. HBV基因型芯片检测方法的研究[J].中华微生物学和免疫学杂志, 2005, 25:603
[66] Chan HL, Hui AY, Wong ML et al. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma[J].Gut,2004, 53:1494-8.
[67] Yuen MF Sablon E, Yuan HJ. Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular [J]. Hepatology, 2003, 37:562-7.
[68] Sumi H, Yokosuka O, Seki N, et al. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease [J] . Hepatology,2003;37(1):19-26.
[69] Chien RN, Yeh CT, Tsai SL, et al.Determinants for sustained HBeAg response to lamivudine therapy[J]. Hepatology,2003, 38(5):1267-73.
[70] Fung SK, Wong F, Hussain M, et al.Sustained response after a 2-year course of lamivudine treatment of hepatitis B e antigen-negative chronic hepatitis b[J].J Viral Hepat,2004, 11(5):432-8.
[71] Wai CT, Chu CJ, Hussain M, et al.HBV genotype B is associated with better response to interferon therapy in HBeAg(+)chronic hepatitis than genotype C[J].Hepatology,2002, 36(6):1425-30.
[72] Zhang X, zoulim F, Habersetzer F, et al.Analysis of hepatitis B virus genotypes and pre-core region variability during interferon treatment of HBe antigen negative chronic hepatitis B[J].J Med Virol,1996, 48(1):8-16.
[73] Kao, J. H., P. J. Chen, M. Y. Lai, et al. Chen. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B[J]. Gastroenterology, 2000. 118:554-9.
[74] Kao JH, Liu CJ, Chen DS. Hepatitis B viral genotypes and lamivudine resistance[J]. J Hepatol,2002, 36:303–4.
[75] Erhardt A, Reineke U, Blondin D,et al. Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B[J]. Hepatology, 2000, 31:716–25.
[76] C L Lin, J D Chen, C J Liu, et al. Clinicopathological differences between hepatitisB viral genotype B- and C-related resectable hepatocellular carcinoma[J]. Journal of Viral Hepatitis,2007, 14(1):64-9.
[77]宋淑静,何忠平,庄辉等.中国北方5城市慢性乙型肝炎患者的基因分型[J].中国公共卫生, 2004, 20:166-7
[78]刘兴,唐红,何芳.乙型肝炎病毒基因型研究新进展[J].世界华人消化杂志, 2006, 14(22):2211-6
[79] J.Yang, K.Xing, R.Deng, et al.Identification of Hepatitis B virus putative intergenotype recombinants by using fragment typing[J].J.Gen.Virol., 2006, 87(8):2203 -15.
[80] Kramvis A, Weitzmann L, Owiredu WK, et al.Analysis of the complete genome of subgroup A hepatitis B virus isolates from South Africa[J].J Gen Virol, 2002, 83(4):835-9.
[81] Kew MC, Kramvis A, Yu MC.et al.Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu-speaking sub-Saharan Africans[J].J Med Virol, 2005, 75(4):513-21.
[82] Kobayashi M, Suzuki F, Arase Y, et al.Infection with hepatitis B virus genotype A in Tokyo, Japan during 1976 through 2001[J].J Gastroenterol, 2004, 39(9):844-50.
[83] Liu WC, Phiet PH, Chiang TY, et al.Five subgenotypes of hepatitis B virus genotype B with distinct geographic and virological characteristics[J].Virus Res,2007,129(2):212-23.
[84] Chan HL, Hui AY, Wong ML et al.Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma[J]. Gut,2004, 53(10):1494-8.
[85] Chu CJ, Hussain M, Lok AS.Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype c[J].Gastroenterology, 2002, 122(7):1756-62.
[86] Orito E, Mizokami M, Sakugawa H, et al.A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C.Japan HBV Genotype Research group[J].Hepatology,2001, 33(1):218-23.
[87] Wang Z, Huang Y, Wen S, et al.Hepatitis B virus genotypes and subgenotypes in China[J].Hepatol Res, 2007, 37(1):36-41.
[88] Akuta N, Suauki F, Kobayashi M et al.The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment[J].J Hepatol,2003, 38(3):315-21.
[89] Orito E, Sugauchi F, Tanaka Y, et al.Differences of hepatocellular carcinoma patients with hepatitis B virus genotypes of Ba, bj or C in Japan[J]. Intervirology, 2005, 48(4):239-45.
[90] Tseng TC, Liu CJ, Chen PJ, et al.Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan[J].Liver Int, 2007, 27(7):983-8.
[91] Shinkai N, Tanaka Y, Ito K, et al.Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2[J].J Clin Microbiol ,2007,45(10):3191-7.
[92] Lazarevic M, Cupic D.Distribution of HBV genotypes, subgenotypes and HBsAg subtypes among chronically infected patients in Serbia[J]. Archives of Virology, 2007, 152(11):2017-25.
[93] Tallo T, Norder H, Tefanova V, et al. Hepatitis B virus genotype D strains from Estonia share sequence similarity with strains from Siberia and may specify ayw4[J]. J Med Virol, 2004, 74(2):221-7.
[94] K.Yalcin, H.Degertekin, I.H.Bahcecioglu, et al.Hepatitis B Virus Genotype D Prevails in Patients with Persistently Elevated or Normal ALT Levels in Turkey Turk[J]. J Gastroenterol,2005, 16(4):183-7.
[95] Norder H, Courouce AM, Coursaget P, et al.Genetic diversity of hepatitis B virus strains derived worldwide:genotypes, subgenotypes, and HBsAg subtypes[J].J Intervirology, 2004, 47(6):289-309.
[96] Mello FC, Souto FJ, Nabuco LC, et al. Hepatitis B virus genotypes circulating in Brazil:molecular characterization of genotype F isolates[J]. BMC Microbiol, 2007,23(7):103.
[97] Cui C, Shi J, Hui L, et al.The dominant hepatitis B virus genotype identified in Tibet is a C/D hybrid[J].J Gen Virol, 2002, 83(11):2773-7.
[98] Zeng G, Wang Z, Wen S, et al.Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China[J].J Viral Hepat, 2005, 12(6):609-17.
[99] Wang Z, Hou J, Zeng G, et al.Distribution and characteristics of hepatitis B virus genotype C subgenotypes in China[J].J Viral Hepat, 2007, 14(6):426-34.
[100]鲁晓擘,王晓岚,邓国宏,等.新疆维吾尔族慢性乙型肝炎患者HBV基因型分布及其特点[J].中华肝脏病杂志,2007, 15:241-4.
[101] Morozov V, Groudinin M, Groudinin M.Homologous recombination betweendifferent genotypes of hepatitis B virus[J]. Gene ,2000, 260(1-2):55-65.
[102] Yano, Yoshihiko; Truong, Bui X.;Seo, Yasushi, et al. Japanese case of hepatitis B virus genotypes C/D hybrid[J]. Hepatology Research, 2007, 37(12):1095-99 .
[103] Bottecchia M, Souto FJ, O KM, et al. Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy:characterization of genotype G in Brazil[J]. BMC Microbiol, 2008, 22(8):11.
[2]焦健.慢性乙型?丙型肝炎遗传易感性研究进展[J].国外医学免疫学分册,2004,225:148-51.
[3] World Health Organization. Hepatitis B. World Health Organization Fact Sheet 204 dex[M]. Revised October 2000.
[4]张申英,张欣欣,陆志檬. HLA复合体与乙型肝炎病毒感染的关系[J].国外医学病毒学分册,2000,7:107-11.
[5] McMahon BJ, Bulkow L, Harpster A et al. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B. a 16-year population-based study[J]. Hepatology, 2000,32:842-6.
[6] Ocama P, Opio CK, Lee WM. Hepatitis B virus infection:current status[J]. Am J Med,2005,118(12):14-13.
[7] Lok AS. Chronic hepatitis B[J]. N Engl J Med, 2002, 346(22):1682-3.
[8]庄辉.乙型肝炎流行病学研究进展[J].《国外医学:流行病学.传染病学分册》,2004,31(3):138.
[9] Jinlin Hou, Zhihua Liu, Fan Gu. Epidemiology and Prevention of Hepatitis B Virus Infection[J]. Int J Med Sci, 2005,2(1):50-57.
[10]梁晓峰,陈园生,王晓军,等.中国3岁以上人群乙型肝炎血清流行病学研究[J].中华流行病学杂志, 2005,26:655- 8?
[11]范金水,庄辉,李远贵,等.我国8城市HBsAg阳性和阴性乙型肝炎患者的病毒血清型和基因型分析[J].中华微生物学和免疫学杂志, 1998, 18:88-91.
[12]骆抗先乙型肝炎基础和临床[M].人民卫生出版社,第三版, 246.
[13] Has R, Yüksel A, Topuz S. Hepatitis B infection in pregnancy:is it really not harmful to the fetus? [J]. Prenat Diagn, 2001 ,21(8):701-2.
[14]孟钊,肖小敏,何明娇,等.乙肝病毒母婴垂直传播阻断的研究[J].实用妇产科杂志, 2005, 6:18-20.
[15]李端. HBV多样性与乙型肝炎传播途径的关系[J].国外医学(病毒学分册),2001,3.
[16]张宜俊,章谷生.乙型肝炎生物治疗[M].上海科学技术出版社, 2001:1-3.
[17]成军.乙型肝炎病毒基因组结构与功能复杂性的新认识[J].世界华人消化杂志, 2003,11(8):1073- 80.
[18]刘妍,成军,陆荫英,等.乙型肝炎病毒蛋白反式激活基因的研究[J].世界华人消化杂志, 2002,10:217-219.
[19]成军,朱传琳.肝炎病毒对双链RNA激酶PKR的调节作用[J].国外医学微生物学分册,2000,23:1-3.
[20] Lee JY, Locarnini S. Hepatitis B virus:pathogenesis, viral intermediates, and viral replication[J]. Clin Liver Dis, 2004,8:301- 20.
[21] Strader DB, Wright T, Thomas DL. et al. Diagnosis, managementand treatment of hepatitis C[J]. Hepatology, 2004, 39∶1147~ 71.
[22] Seeger C, Maso W. Hepatitis B virus biology[J]. Microbiol Mol Biol Rev, 2004, 64∶51~68.
[23] H. Guo, D. Jiang, T. Zhou, A. et al. Characterization of the Intracellular Deproteinized Relaxed Circular DNA of Hepatitis B Virus:an Intermediate of Covalently Closed Circular DNA Formation[J]. J. Virol., 2007,81(22):12472 - 84.
[24] Fabien Zoulim . Antiviral therapy of chronic hepatitis B:can we clear the virus and prevent drug resistance? [J].Antivir Chem Chemother, 2004,15(6):299-305.
[25] Augustine Chen, Y. F. Kao , Chris M. Brown. Translation of the first upstream ORF in the hepatitis B virus pregenomic RNA modulates translation at the core and polymerase initiation codons[J]. Nucleic Acids Research, 2005,33(4):1169- 81.
[26] Patrick Soussan, Florianne Garreau, Herve Zylberberg, et al. In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA[J]. J Clin Invest, 2000 ,105(1):55–60.
[27]董梅,张跃新.乙型肝炎病毒基因型的分布及临床意义[J].中华肝脏病杂志, 2005, 13(1):56-57 .
[28]夏国良, Omana V,贾志远,等.单纯乙型肝炎疫苗免疫后携带者表面抗原氨基酸置换的频率和特征[J].中华实验和临床病学杂志, 2001, 15:212- 15.
[29]闫伯英,胡志东.乙型肝炎病毒变异的临床研究进展[J].国际病毒学杂志, 2006, 13(1):29- 32.
[30] Hu KQ. Occult hepatitis B virus infection and its clinical implica tions[J]. J Viral Hepat, 2002, 9:243-57.
[31] Wallace LA, Carman WF. Surface gene variant of HBV:scientific and medical relevance[J]. Vir Hep Revs, 1997, 3:5 -16.
[32] Tang JH, Yeh CT, Chen TC, et al Emergence of an S gene mutant during thymosin alpha-1 therapy in a patient with chronic hepatitis B[J]. J Infect Dis ,1998, 178:866-8 69.
[33] Carman WF, Frederick J, Van deursen1 The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia1[J]. Hepatology, 1997, 26:16582- 661.
[34] Carman WF, Korula J, Wallace LA1. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA[J]. Lancet, 1995, 345:14062- 071.
[35] H. E. Kohrt,D. L. Ouyang,E. B. Keeffe.Lamivudine Prophylaxis for Chemotherapy-Induced Reactivation of Chronic Hepatitis B Virus [J]. Infection Aliment Pharmacol Ther,2006,24(7):1003- 16.
[36] Chong Jin Oon, Shiuan Koh Horizontal .Transmission of a Hepatitis B Virus Surface Antigen Mutant [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000,38(2):938– 9 ..
[37] Hou J, Wang Z, Cheng J, et al. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface[J] .World J Gastroenterol ,2005,11(13):2004- 8.
[38] Hong-Zhi Yang, Jian-An Zhao, Min Dai, et al. Traditional Chinese medicine syndromes of chronic hepatitis B with precore mutant antigen-negative Chinese carriers[J]. Hepatology, 2001,34(5):1027-34.
[39] Davaalkham, T. Ojima, R. Uehara et al. Analysis of hepatitis B surface antigen mutations in Mongolia:Molecular epidemiology and implications for mass vaccination_D[J]. Arch Virol, 2007, 152:575–84.
[40] H Okamoto, F Tsuda, Y Akahane, et al .Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen[J]. J Virol, 1994, 68(12):8102–10.
[41]高学松,成军,甄真,等.乙型肝炎核心启动子的研究进展[J].世界华人消化杂志, 2005, 13(8):933-6.
[42] HAMATAKE Robert K, LAU Johnson Y.N. Hepatitis B and D protocols, Volume 1 : detection, genotypes and characterization , (Methods in molecular medicine, Vol. 95) [M] 2004,2.
[43] Lieven Stuyver, Sija De Gendt, Caroline Van Geyt . A new genotype of hepatitis B virus:complete genome and phylogenetic relatedness[J]. Journal of General Virology , 2000,81:67-74.
[44] Henry Lik-Yuen Chan, Woon-Choi Tsang, Chook-Tiew Liew. Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage inHBeAg-negative chronic hepatitis B virus infection[J] .The American Journal of Gastroenterology, 2002,97(2):406-12.
[45] Cheng Y, Seet BL, Ong CS, et al. Are in vitro hepatitis B core promoter mutations important for clinical alterations in viral load ? [J].Antiviral Res, 2006, 69(3):142- 51.
[46] Buti M, Rodriguez- Frias F, Jardi R. Hepatitis B virus genome variability and disease progression:the impact of pre-core mutants and HBV genotypes[J]. J Clin Virol,2005, 34(Suppl 1):S79-82.
[47] Le Pogam S, Yuan TT, Sahu G, et al. Low-level secretion of human hepatitis B virus virions caused by two independent, naturallyoccurring mutations(P5T and L60V)in the capsid protein[J]. J Virol, 2000,74(19):9099-105.
[48]朱佳莉,张欣欣.乙型肝炎病毒复制特点及其重要基因变异[J]. Inter J Epidemiol Infect Dis, 2006,33(8):4251-4.
[49] Kuang SY, Jackson PE, Wang JB, et al. Specific mutations of hepatitis B Kuang SY, virus in plasma predict liver cancer development[J]. J.PNAS, 2004,101(10):3575- 80.
[50] Scaglioni PP, Melegari M, Wands JR. Biologic properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame[J]. Virology, 1997, 233:374-81.
[51] Locarnini S, Shaw T, Dean J, et al. Cellular response to conditional expression of the hepatitis B virus precore and core proteins in cultured hepatoma(Huh-7)cells. J Clin Virol.2005;32(2):113- 21.
[52] Hiroshi Y Elichi T Elichi T. Precore and core promoter mutations hepatitis B virus DNA levels and progressive liver injury in chronic hepatitis B[J]. HEPATOLOGY, 2002,37:355- 63.
[53] Lindh M, Andersson AS, Gusdal A. Genotypes, nt1858 variants, and geographiorigin of hepatitis B virus-large scale analysis using a new genotyping method[J]. J Infect Dis, 1997,175:1285- 93.
[54] Bartholomew MM, Jeffers L.J.Hepatitis B virus resistence to lamivudine given for recurrent infection atter orthotopic liver transplantation[J]. LANCET, 1997,349:20- 22 .
[55] Sadakazu Usuda, Hiroaki Okamoto, Hiroko Iwanari et al .Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product. Immunology[J]. Journal of VirologicalMethods.1999,80(1):97-112.
[56] Lai CL, Dienstag J, Schiff E, et al. Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B[J]. Clin Infect Dis,2003,36:687-96.
[57] Lai CL, Dienstag J, Schiff E, et al. Prevalence and clinical corre2 lates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B[J]. Clin Infect Dis,2003,36:687-96.
[58]熊笑风.乙型肝炎病毒耐药性研究进展[ J].肝脏杂志.2006;11(4):273- 5.
[59] Stuyver LJ, Locarnini SA, Lok A, et al. Nonenclature for antiviral–resistant human hepatitis B virus mutations in the polymerase region[J]. Hepatology, 2001,33(3):751- 7.
[60] WRIGHT T L. Clinical trail results and treatment resistance with Lamivudine in hepatitis B[J] . Seminars liver disease , 2004, 24: 31-36.
[61]许东,田德英,王卫华,等.乙型肝炎病毒YMDD及e抗原相关多重变异及临床意义[J].中华内科杂志,2004,43(2):121-4.
[62] Stuyver LJ, Locarnini SA, Lok A, et al. Nomenclature for antiviralresistant human hepatitis B virus mutations in the polymerase region[J]. Hepatology, 2001,33(3): 751-7.
[63] Delaney WE 4th, Locarnini S, Shaw T. Resistance of hepatitis B virus to antiviral drugs:current aspects and directions for future investigation[J]. Antivir Chem Chemother, 2001,12(1):1-35.
[64] Zollner B, Petersen J, Puchhammer-Stockl E, et al. Viral features of lamivudine resistant hepatitis B genotypes A and D[J]. Hepatology,2004,39(1):42-50.
[65] Akuta N, Suzuki F, Kobayashi M,et al. The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment[J]. J Hepatol , 2003,38:315-21.
[66] Delan ey We4th, Yang H, Westland CE, et al. The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro[J]. J Virol,2003, 77(21):11833- 41.
[67] Angus P, Vaughan R, Xiong S, et al. Resistance to adefovir dipivoxil therapy associated with development of a novel mutation in the HBV polymerase[J]. Gastroenterology,2003,125(2):292-7.
[68] Bartholomeusz A, Locarnini S, Ayres A, et al. Molecular modelling of hepatitis B virus polymerase and adefovir resistance identifies three clusters of mutations[J].Hepatology, 2004,40:246 .
[69]张欣欣.乙型肝炎病毒耐药突变产生的分子病毒学机制[J].肝脏杂志, 2006, 11[增刊]:1- 4.
[70] Tenney DJ, Levine SM, Rose RE, et al. Clinical emergence of entecavir- resistant hepatitis B virus requires additional substitutions in virus already resistant to lamivudine[J]. Antimicrob Agents Chemother,2004, 48(9):3498-507.
[71] Pawlotsky JM. The concept of hepatitis B virus mutant escape[J]. J Clin Virol,2005, 34(Suppl 1):125-9.
[72] Colonno R, Rose R, Levine S, et al. Entecavir two year resistance update:no resistance observed in nucleoside naive patients and low frequency resistance emergence in lamivudine refractory patients[J]. J. Hepatology,2005, 42(1):267.
[73] Alexandra Valsamakis. Molecular Testing in the Diagnosis and Management of Chronic Hepatitis B [J].J CLINICAL MICROBIOLOGY REVIEWS,2007, 7:426-39.
[74] Okamoto H, Tsuda F, Sakugawa H, et al. Typing hepatitis B virus by homology in nucleotide sequence:comparison of surface antigen subtypes[J]. J Gen Virol, 1988, 69:2575-83.
[75] Stuyver L, DeGendt S, VanGeyt C, et al. . A new genotype of hepatitis B virus:complete genome and phylogenetic relatedness[J]. J Gen Virol,2000, 81:67-74.
[76] Arauz-Ruiz P, Norder H, Robertson BH, et al. Genotype H:a new Amerindian genotype of hepatitis B virus revealed in Central America[J]. J Gen Virol,2002, 83:2059-73.
[77] Tsubota A, Arase Y, Ren F, et al. Genotype may correlate with liver carcinogenesis and tumor characteristics in cirrhotic patients infected with hepatitis B virus subtype adw[J]. J Med Virol,2001, 65:257-65.
[78]杨夏,张跃新,朱滨等. HBV基因型芯片检测方法的研究[J].中华微生物学和免疫学杂志, 2005,25:603.
[79] G. Zeng, Z. Wang, S. Wen et al. Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China[J]. Journal of Viral Hepatitis, 2005, 12(6):609-17.
[80] Chan HL, Leung NW, Hussain M, et al. Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong[J]. Hepatology, 2000, 31:763- 8.
[81] Arauz-Ruiz P, Norder H, Robertson BH, et al. Genotype H:a new Amerindiangenotype of hepatitis B virus revealed in Central America[J]. J Gen Virol,.2002, 83:2059-73.
[82] Sumi H, Yokosuka O, Seki N,et al. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease[J]. Hepatology, 2003,37:19-26.
[83] Chan HL, Tsang SW, Liew CT, et al. Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection[J]. Am J Gastroenterol, 2002, 97:406-12.
[84] Ding X, Mizokami M, Ge X, et al. Different hepatitis B virus genotype distributions among asymptomatic carriers and patients with liver diseases in Nannning, southern China[J]. Hepatol Res,2002, 22:37-44.
[85]许军,王齐欣,蒋栋,等.乙型肝炎病毒基因型与病情轻重的关系[J].中华肝脏病杂志,2003, 11:11-13.
[86]李卓,李洪权,李俊红,等.北京地区乙型肝炎病毒基因型与其感染临床表型的相关性[J].世界华人消化杂志, 2005, 13(24):2823-27.
[87] Huy TT, Ushijima H, Win KM, et al. High p revalence of hepatitis B virus p re2smutant in countrieswhere it is endemic and its relationship with genotype and chronicity [J] . J Clin Microbiol, 2003, 41:5449-55.
[88] Duong TN, Horiike N, Michitaka K, et al. Comparison of genotypes C and D of the hepatitisB virus in Japan:a clinical and molecular biological study [J] . J Med Virol, 2004, 72:551-7.
[89] Mayerat C, Mantegani A, Frei PC. Does hepatitis B virus(HBV)genotype influence the clinical outcome of HBV infection[J]. J Viral Hepat,1999, 6:299-304.
[90]沈建坤,周荣,王战会,等.实时荧光聚合酶链反应检测HBV基因型B~D方法的建立[J] .第一军医大学学报, 2005, 25:630-2.
[91] Yotsuyanagi H, Okuse C, Yasuda K, et al. Distinct geographic distributions of hepatitis B virus genotypes in patients with acute infection in Japan[J]. J Med Virol,2005, 77:392-46.
[92] Kao JH, Wu NH, Chen PJ, et al. HepatitisB genotypes and the response to interferon therapy [J]. J Hepatol,2001, 35:829-30.
[93] Sakai T, Shiraki K, Inoue H, et al. Efficacy of long-term interferon therapy in chronic hepatitis B patientswith HBV geno-type C [J] . Int J MolMed,2002, 10:201-4.
[94]周建良,吴诗品.拉米呋啶治疗乙型肝炎病毒B?C基因型疗效比较[J].中华肝脏病杂志, 2004, 12:489-90.
[95]刘兴,唐红,何芳.乙型肝炎病毒基因型研究新进展[J].世界华人消化杂志. 2006, 22:17-9.
[96] Wang, Z. Hou, J. Zeng, G. et al. Distribution and characteristics of hepatitis B virus genotype C subgenotypes in China[J]. Journal of Viral Hepatitis,2007, 14(6):426-34.
[97] Wang Z, Huang Y, Wen S, et al. Hepatitis B virus genotypes and subgenotypes in China[J]. Hepatol Res, 2007,37(1):36-41.
[98] Cui C, Shi J, Hui L, et al. The dominant hepatitis B virus genotype identified in Tibet is a C/D hybrid[J]. J Gen Virol, 2002,83(11):2773-7.
[99] Tseng TC, Liu CJ, Chen PJ,et al. Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan[J]. Liver Int, 2007,27(7):983-8.
[100] Zeng GB, Wen SJ, Wang ZH. A novel hepatitis B virus genotyping system by using restriction fragment length polymorphism patterns of S gene amplicons [J].World J Gastroenterol, 2004,10(21):3132- 6.
[101] Sugauchi F, Kumada H, Sakugawa H, et al. Two subtypes of genotype B(Ba and Bj)of hepatitis B virus in Japan[J]. Clin Infect Dis, 2004,38(9):1222-8.
[102] Tanaka, Y., M. Mukaide, E. Orito, et al. Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma[J]. J. Hepatol,2006, 45:646-53.
[103]房继莲,魏来,李若冰,等. INNO2LiPA乙型肝炎病毒基因分型方法的评价[J].中华检验医学杂志,2004, 27(12):846-8.
[104] Bartholomeusz, A., Schaefer S. Hepatitis B virus genotypes:comparison of genotyping methods[J]. Rev. Med. Virol,2004, 14:3-16.
[105] Usuda S, Okamoto H, Tanaka T, et al. Differentiation of hepatitis B virus genotypes D and E by ELISA using monoclonal antibodies to epitopes on the preS2-region product[J]. Journal of virological methods, 2000, 87(2):81-89.
[106] Sugauchi F, Orito E, Ichida T, et al. Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C[J]. Gastroenterology, 2003, 124:925-32.
[107] Huy TT, Ushijima H, Quang VX, et al. Genotype C of hepatitis B virus can be classified into at least two subgroups[J]. J Gen Virol , 2004,85:283-92.
[108] Chu CJ, Keeffe EB, Han SH, et al. Hepatitis B virus genotypes in the United States:results of a nationwide study[J]. Gastroenterology, 2003, 125(2):444-51.
[109] Luo K, Liu Z, He H. et al. The putative recombination of hepatitis B virus genotype B with pre-c/c region of genotype C[J]. Virus Genes, 2004,29:31-41.
[110]鲁晓擘,王晓岚,邓国宏,等.新疆维吾尔族慢性乙型肝炎患者HBV基因型分布及其特点[J].中华肝脏病杂志, 2007, 15(4):241-244.
[111] Bollyky PL, Harvey PH. Recombination between sequences of hepatitis B virus from different genotypes[J].Journal of Molecular Evolution, 1996, 42:97-102.
[112] Bowyer, S. M. and Sim, J. G.(2000):Relationships within and between genotypes of hepatitis B virus at points across the genome:footprints of recombination in certain isolates[J]. J. Gen. Virol., 81, 379- 92.
[113] Huy Thien-Tuan Tran, Hiroshi Ushijima, Trinh Thi Ngoc, et al. Recombination of Genotypes B and C in Hepatitis B Virus Isolated from a Vietnamese Patient with Fulminant Hepatitis[J]. Jpn. J. Infect. Dis,2003, 56(1):35-37.
[114] Yano Y, Truong BX, Seo Y, et al. Japanese case of hepatitis B virus genotypes C/D hybrid[J]. Hepatol Res, 2007, 37(12):1095-9.
[115] Sugauchi F, Orito E, Ichida T, et al. Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C[J]. Gastroenterology, 2003 ,12(4):925-32.
[116] Yuen MF, Sablon E, Tanaka Y, et al. Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong Kong[J]. J Hepatol, 2004, 41:119-25.
[117]温志立,谭德明.多对型特异性引物巢式PCR检测湖南省乙肝病毒基因型[J].世界华人消化杂志, 2004,12:332-5.
[118] Liu CJ, Chen BF, Chen PJ .Role of viral factors in the natural course and therapy of chronic hepatitis B[J] .Hepatology International, 2007, 12(1):415-30.
[119] Chan, H. L. Y., Tsui, S. K. W., Tse Chi Hang. Epidemiological and virological characteristics of 2 subgroups of hepatitis B virus genotype C[J]. Journal of Infectious Diseases, 2005, 191(12):2022-32.
[120] Hou J, Lau GK, Cheng J et al. T1762/A1764 variants of the basal core promoter of hepatitis B virus;serological and clinical correlations in Chinese patients[J]. Liver, 1999,19(5):411-7.
[121] Liu C J, K aoJ H, L aiM Y, et a l. P recore/corep romoterm utationsa ndgen otypeso fh epatitisB virusin c hronich epatitisB patients withful mi nan to rsu bfulminanth epatitis[J]. J M edV irol, 2004,72(4):545-50.
[122] Ling R, Mutimer D, Ahmed M, et al. Selection of mutations in the hepatitis B viruspolymerase during therapy of transplant recipients with lamivudine[J]. Hepatology, 1996, 24:711- 13.
[123] Tipples GA, Ma MM, Fischer KP. et al. Mutation in HBV RNA dependent DNA polymerase confers resistance to lamivudine in vivo[J]. Hepatology, 1996, 24:714-7.
[124] Kobayashi S, Ide T, Sata M. Detection of YMDD motif mutations in some lamivudine untreated asymptomatic hepatitis B virus carriers[J]. J Hepatol, 2001, 34:584-6.
[125]霍红,赵书民,蔡雄,等. YMDD自然变异毒株流行病学调查[J].肝脏, 2006, 4:232-4.
[126] Stuyver LJ, Locarnini SA, Lok A, et al. Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region[J]. Hepatology,2001,33:751–7.
[127] Bozdayi AM, Uzunalimoglu O, Turkyilmaz AR, et al. YSDD:a novel mutation in HBV DNA polymerase confers clinical resistance to lamivudine[J]. J Viral Hepat,2003,10(4):256-65.
[128] Bock CT, Tillmann H, Torresi J, et al. Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplanta- tion[J]. Gastroenterology, 2002, 122(2);264-73.
[129] Torresi J, Earnest-Silveira L, Deliyannis G, et al. Reduced Antigenicity of the Hepatitis B Virus HBsAg Protein Arising as a Consequence of Sequence Changes in the Overlapping Polymerase Gene That Are Selected by Lamivudine Therapy[J]. Virology ,2002, 293(2):305-13.
[130] Torresi J. The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus[J]. J Clin Virol, 2002,25(2):97- 106.
[131] Angus P, Vaughan R, Xiong S, et al. Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase[J]. J Gastroenterology, 2003, 125(2):292-7.
[132] Lin X, Yuan ZH, Wu L, et al. A single amino acid in the reverse transcriptase domain of hepatitis B virus affects virus replication efficiency[J]. J Virol,2001, 75(23):11827-33.
[133] Kao JH, Liu CJ, Chen DS. Hepatitis B viral genotypes and lamivudine resistance[J]. J Hepatol, 2002, 36:303– 4.
[1]董梅,张跃新.乙型肝炎病毒基因型的分布及临床意义[J].中华肝脏病杂志, 2005, 13:56-57 .
[2]李雅娟,庄辉.乙型肝炎病毒基因亚型研究进展[J].传染病信息, 2005,18(4):176.
[3]徐红,张跃新,魏来,等.新疆汉族人群HBV基因型与临床病情的关系[J].实用肝脏病杂志, 2005,8(1):11-15.
[4]徐红张跃新肖琳等新疆地区汉族人群乙型肝炎病毒基因型的分布及其与临床类型的关系[J].中华肝脏病杂志, 2005, 13(11):848-9.
[5] Miyakawa Y, Mizokami M. Classifying hepatitis B virus genotypes[J]. Intervirology ,2003,46:329-38.
[6] Norder H, Courouc AM, Coursaget P, et al. Genetic diversity of hepatitis B virus strains derived worldwide:genotypes, subgenotypes, and HBsAg subtypes[J]. Intervirology, 2004, 47:289-309.
[7] Bowyer, S.M. and Sim, J.G.Relationships within and between genotypes of hepatitis B virus at points across the genome:footprints of recombination in certain isolates[J]. Gen. Virol,2000, 81: 379-92.
[8] Bartholomeusz A, Schaefer S. Hepatitis B Virus Genotypes:Comparison of genotyping methods[J] . Reviews in Medical Virology. Bartholomeusz A, 2004, 14:3-16.
[9] Hou J, Liu Z, Gu F. Epidemiology and prevention of hepatitis B virus infection[J] . Int J Med Sci ,2005, 2(1):50-57.
[10] Miyakawa Y, Mizokami M. Classifying hepatitis B virus genotypes[J]. Intervirology, 2003, 46:329-38.
[11] Alexandra Valsamakis.Molecular Testing in the Diagnosis and Management of Chronic Hepatitis B[J]. J CLINICAL MICROBIOLOGY REVIEWS 2007, 7:426-39.
[12] Moskovitz DN, Osiowy C, Giles E et al.Response to long-term lamivudine treatment(up to 5 years)in patients with severe chronic hepatitis B, role of genotype and drug resistance[J]. Journal of Viral Hepatitis. Moskovitz DN Giles E Giles E, 2005, 12(4):398-404.
[13] Yuen MF, Yuan HJ, Yuan HJ et al. Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, andhepatocellular[J]. Hepatology, 2003, 37:562-7.
[14] Yuen MF, Sablon E, Tanaka Y, et al.Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong Kong[J].J Hepatol, 2004, 41:119-125.
[15] Jazayeri MS, Basuni AA, Cooksley G, et al.Hepatitis B virus genotypes, core gene variability and ethnicity in the Pacific region[J].J Hepatol,2004, 41:139-146.
[16] Kato H, Orito E, Gish RG, et al.Characteristics of hepatitis B virus isolates of genotype G and their phylogenetic differences from the other six genotypes(A through F) [J].J Virol ,.2002, 76:6131-7.
[17] Kramvis A, Weitzmann L, Owiredu WK, et al. Analysis of the complete genome of subgroup A' hepatitis B virus isolates from South Africa[J]. J Gen Virol ,2002, 83:835-9.
[18] Kimbi GC, Kew MC, Kew MC et al.Distinctive sequence characteristics of subgenotype A1 isolates of hepatitis B virus from South Africa[J]. J Gen Virol, 2004, 85(5):1211-20.
[19] Chan HL, Leung NW, Hussain M, et al.Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong[J].Hepatology, 2000, 31:763-8.
[20] Tsubota A, Arase Y, Ren FT.Genotype may correlate with liver carcinogenesis and tumor characteristics in cirrhotic patients infected with hepatitis B virus subtype adw[J].J Med Virol, 2001, 65:257-65.
[21] Arauz-Ruiz P, Norder H, Robertson BH, et al.Genotype H:a new Amerindian genotype of hepatitis B virus revealed in Central America[J].J Gen Virol, 2002, 83:2059-73.
[22] Ding X, Mizokami M, Ge X, et al.Different hepatitis B virus genotype distributions among asymptomatic carriers and patients with liver diseases in Nannning, southern China[J]..Hepatol Res, 2002, 22:37-44.
[23]许军,王齐欣,蒋栋,等.乙型肝炎病毒基因型与病情轻重的关系[J]..中华肝脏病杂志, 2003, 11:11-13.
[24] Wai CT, Fontana RJ, Polson J, et al.Clinical significance of hepatitis B virus genotypes, variants, and mutants[J].Clin liver dis,2004, 8(2):321-52, vi .
[25] Lindh M, Hannoun c, dhillon AP, et al.Core promoter mutations and genotypes in relation to viral replication and liver damage in East asian hepatitis B virus carriers[J].J infect Dis,1999, 179(4):775-82
[26] Magnius LO, Norder H.Subtypes, genotypes and molecular epidemiology of thehepatitis b virus as reflected by sequence variability of the S-gene[J]. Intervirology, 1995, 38(1-2):24-34.
[27] Bartholomeusz A, Schaefer S.Hepatitis B virus genotypes:comparison of genotyping methods[J]. Rev Med Virol,2004, 14(1):3-16.
[28] Huy TT.Ushijima H, Quang VX, et al.Genotype C of hepatitis B virus can be classified into at least two subgroups[J].J Gen Virol,2004, 85(2):283-92.
[29] Kurbanov F, Tanaka Y, Fujiwara K, et al. A new subtype(subgenotype)Ac(A3)of hepatitis B virus and recombination between genotypes A and E in Cameroon[J]. J Gen Virol, 2005, 86:2047-56.
[30] Sugauchi F, Kumada H, Sakugawa H, et al. Two subtypes of genotype B(Ba and Bj)of hepatitis B virus in Japan[J]. Clin Infectious Dis, 2004, 38:1222-8.
[31] Norder H, Courouce AM, Coursaget P, et al . Genetic diversity of hepatitis B virus strains derived worldwide:Genotypes, subgenotypes and HBsAg subtypes[J]. Intervirology ,2004, 47:289-309.
[32] Sugauchi F, Orito E, Ichida T, et al . Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene[J]. J Virol, 2002, 76:5985-92.
[33] Norder H, Courouce AM, Coursaget P, et al . Genetic diversity of hepatitis B virus strains derived worldwide:Genotypes, subgenotypes and HBsAg subtypes[J]. Intervirology, 2004, 47:289-309.
[34] Chan HL, Tsui SK, Tse CH, et al . Epidemiological and virological characteristics of 2 subgroups of hepatitis B virus genotype C[J]. J Infect Dis, 2005, 191:2022-32.
[35] Huy TT, Quang VX. Genotype C of hepatitis B virus can be classified into at least two subgroups[J] .Journal of General Virology, 2004, 85(2):283- 92.
[36] Helene Norder, Anne-Marie Couroucé, Pierre Coursaget, et al Genetic Diversity of Hepatitis B Virus Strains Derived Worldwide:Genotypes, Subgenotypes, and HBsAg Subtypes[J]. Intervirology ,2004, 47:289-309.
[37] Fuat Kurbanov, Yasuhito Tanaka, Kei Fujiwara, et al.A new subtype(subgenotype) Ac(A3) of hepatitis B virus and recombination between genotypes A and E in Cameroon[J]. J Gen Virol,2005, 86:2047- 56.
[38] Lindh M, Andersson AS, Gusdal A.Genotypes, nt1858 variants and geographic origin of hepatitis B virus-large-scale analysis using a new genotyping method[J].J Infect Dis, 1997, 175(6):1285-93.
[39] Lindh M, Gonzalez JE, Norkrans G et al.Genotyping of hepatitis B virus byrestriction pattern analysis of a pre-s amplicon[J]. J Virol methods,1998, 72(2):163-74.
[40] Mizokami M, Nakano T, Orito E et al.Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns[J].FEBSLett, 1999,450(1-2):66- 71.
[41] Zeng GB, Wen SJ, Wang ZH, et al.A novel hepatitis B virus genotyping system by using restriction fragment length polymorphism patterns of S gene amplicons[J]. World J Gastroenterol,2004, 10(21):3132-6.
[42] Hasegawa I, Kramvis A.Novel hepatitis B virus genotype a subtyping assay that distinguishes subtype Aa from Ae and its application in epidemiological studies[J].Journal of Virology. 2004, 78:7575- 81.
[43] Tanaka Y, Hasegawa I, Kato T,et al.A case-control study for differences among hepatitis B virus infections of genotypes A(subtypes Aa and Ae)and D[J].J Hepatology, 2004, 40(3):747-55.
[44] Nakayoshi, T., Maeshiro, T., Nakasone, H. et al.. Difference in prognosis between patients infected with hepatitis B virus with genotype B and those with genotype C in the Okinawa Islands: a prospective study[J]. Journal of Medical Virology, 2003,70: 350–4.
[45] Arauz-Ruiz, P., Norder, H., Robertson, B. H. et al.. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America[J]. Journal of General Virology, 2002,83:2059–73.
[46] Huy, T, Ushijima, H, Quang, V. X., et al. Genotype C of hepatitis B virus can be classified into at least two subgroups[J]. J. Gen. Virol,2004, 85:283-92.
[47] Norder H, Hammas B, Lofdahl S, et al.Comparison of the amino acid sequence of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains[J].J Gen Virol, 1992, 73(5):1201-8.
[48] Naito H, Hayashi S, Abe K.Rapid and specific genotyping system for hepatitis B virus corresponding to six major genotypes by PCR using typespecific primers[J].J Clin Microbiol, 2001, 39(1):362-4.
[49] Kirschberg O, Repp R, et al. A Multiplex-PC R to Identify Hepatitis B Virus-genotypes A-F[J]. J Clin Virol,2004, 29:39-43..
[50] Hasegawa I, Tanaka Y, Kramvis A .Novel hepatitis B virus genotype a subtyping assay that distinguishes subtype Aa from Ae and its application in epidemiological studies[J] .Journal of Virology, 2004, 78:7575-81.
[51] Andreasson H, Asp A, A1derborn A, et al. Mitochondrial sequence analysis for forensic identification using pyrosequencing technology[J].Biotechniques, 2002, 32(1):124-6.
[52]房继莲魏来李若冰等. INNO2LiPA乙型肝炎病毒基因分型方法的评价[J].中华检验医学杂志,.2004, 27(12):846-8.
[53] Sija De Gendt, Fred Shapiro, Jelena Juras, et al.Hepatitis B Viral Genotyping with the Research INNO-LiPA HBV Genotyping Line Probe Assay[J]. Infectious Diseases J ,2004, 28(1):175-186 .
[54] Grandjacques C, pradat P, stuyver L, et al.Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome:correlation with viral persistence and disease severity[J].J hepatol,2000, 33(3):430-9.
[55]王小红,何忠平,庄辉等.乙型肝炎病毒聚合酶链反应基因分型法的建立及应用[J].中华肝脏病杂志,2003, 5:35-9
[56] Wai CT, Fontana RJ.clinical significance of hepatitis B virus genotypes, variants, and mutants[J].clin Liver Dis,2004;8(2):321-52.
[57] Hussain M, Chu CJ, sablon E, et al.Rapid and sensitive assays for determination of hepatitis B virus(HBV)genotypes and detection of HBV precore and core promoter variants[J].J Clin Microbiol,2003, 41(8):3699-705.
[58] Osiowy C, Giles E.Evaluation of the INNO-LiPA HBV genotyping assay for determination of hepatitis B virus genotype[J].J Clin Microbiol, 2003,41(12): 5473-7.
[59] Bartholomeusz, A., and Schaefer S.Hepatitis B virus genotypes:comparison of genotyping methods[J].Rev.Med.Virol,2004, 14:3-16.
[60] Usuda S, Okamoto H, Tanaka T, et al., Differentiation of hepatitis B virus genotypes D and E by ELISA using monoclonal antibodies to epitopes on the preS2-region product[J].Journal of virological methods ,2000, 87(2):81-89.
[61] Usuda S, Okamoto H, Iwanari H, et al.Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product[J].J Virol Methods,1999, 80(1):97-112.
[62] Kato H, Orito E, sugauchi F, et al.Determination of hepatitis B virus genotype G by polymerase chain reaction with hemi-nested primers[J].J Virol Methods,2001, 98(2):153-64
[63] Moriya T, Kuramoto IK, Yoshizawa H, et al.Distribution of hepatitis B virusgenotypes among American blood donors determined with a PreS2 epitope enzyme-linked immunosorbent assay kit[J].J Clin Microbiol,2002, 40(3):877-80.
[64] Luo K, Liu Z, He H, et al.The putative recombination of hepatitis B virus genotype B with pre-C/C region of genotype C[J].Virus genes,2004, 29(1):31-41.
[65]杨夏,张跃新,朱滨等. HBV基因型芯片检测方法的研究[J].中华微生物学和免疫学杂志, 2005, 25:603
[66] Chan HL, Hui AY, Wong ML et al. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma[J].Gut,2004, 53:1494-8.
[67] Yuen MF Sablon E, Yuan HJ. Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular [J]. Hepatology, 2003, 37:562-7.
[68] Sumi H, Yokosuka O, Seki N, et al. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease [J] . Hepatology,2003;37(1):19-26.
[69] Chien RN, Yeh CT, Tsai SL, et al.Determinants for sustained HBeAg response to lamivudine therapy[J]. Hepatology,2003, 38(5):1267-73.
[70] Fung SK, Wong F, Hussain M, et al.Sustained response after a 2-year course of lamivudine treatment of hepatitis B e antigen-negative chronic hepatitis b[J].J Viral Hepat,2004, 11(5):432-8.
[71] Wai CT, Chu CJ, Hussain M, et al.HBV genotype B is associated with better response to interferon therapy in HBeAg(+)chronic hepatitis than genotype C[J].Hepatology,2002, 36(6):1425-30.
[72] Zhang X, zoulim F, Habersetzer F, et al.Analysis of hepatitis B virus genotypes and pre-core region variability during interferon treatment of HBe antigen negative chronic hepatitis B[J].J Med Virol,1996, 48(1):8-16.
[73] Kao, J. H., P. J. Chen, M. Y. Lai, et al. Chen. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B[J]. Gastroenterology, 2000. 118:554-9.
[74] Kao JH, Liu CJ, Chen DS. Hepatitis B viral genotypes and lamivudine resistance[J]. J Hepatol,2002, 36:303–4.
[75] Erhardt A, Reineke U, Blondin D,et al. Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B[J]. Hepatology, 2000, 31:716–25.
[76] C L Lin, J D Chen, C J Liu, et al. Clinicopathological differences between hepatitisB viral genotype B- and C-related resectable hepatocellular carcinoma[J]. Journal of Viral Hepatitis,2007, 14(1):64-9.
[77]宋淑静,何忠平,庄辉等.中国北方5城市慢性乙型肝炎患者的基因分型[J].中国公共卫生, 2004, 20:166-7
[78]刘兴,唐红,何芳.乙型肝炎病毒基因型研究新进展[J].世界华人消化杂志, 2006, 14(22):2211-6
[79] J.Yang, K.Xing, R.Deng, et al.Identification of Hepatitis B virus putative intergenotype recombinants by using fragment typing[J].J.Gen.Virol., 2006, 87(8):2203 -15.
[80] Kramvis A, Weitzmann L, Owiredu WK, et al.Analysis of the complete genome of subgroup A hepatitis B virus isolates from South Africa[J].J Gen Virol, 2002, 83(4):835-9.
[81] Kew MC, Kramvis A, Yu MC.et al.Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu-speaking sub-Saharan Africans[J].J Med Virol, 2005, 75(4):513-21.
[82] Kobayashi M, Suzuki F, Arase Y, et al.Infection with hepatitis B virus genotype A in Tokyo, Japan during 1976 through 2001[J].J Gastroenterol, 2004, 39(9):844-50.
[83] Liu WC, Phiet PH, Chiang TY, et al.Five subgenotypes of hepatitis B virus genotype B with distinct geographic and virological characteristics[J].Virus Res,2007,129(2):212-23.
[84] Chan HL, Hui AY, Wong ML et al.Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma[J]. Gut,2004, 53(10):1494-8.
[85] Chu CJ, Hussain M, Lok AS.Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype c[J].Gastroenterology, 2002, 122(7):1756-62.
[86] Orito E, Mizokami M, Sakugawa H, et al.A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C.Japan HBV Genotype Research group[J].Hepatology,2001, 33(1):218-23.
[87] Wang Z, Huang Y, Wen S, et al.Hepatitis B virus genotypes and subgenotypes in China[J].Hepatol Res, 2007, 37(1):36-41.
[88] Akuta N, Suauki F, Kobayashi M et al.The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment[J].J Hepatol,2003, 38(3):315-21.
[89] Orito E, Sugauchi F, Tanaka Y, et al.Differences of hepatocellular carcinoma patients with hepatitis B virus genotypes of Ba, bj or C in Japan[J]. Intervirology, 2005, 48(4):239-45.
[90] Tseng TC, Liu CJ, Chen PJ, et al.Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan[J].Liver Int, 2007, 27(7):983-8.
[91] Shinkai N, Tanaka Y, Ito K, et al.Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2[J].J Clin Microbiol ,2007,45(10):3191-7.
[92] Lazarevic M, Cupic D.Distribution of HBV genotypes, subgenotypes and HBsAg subtypes among chronically infected patients in Serbia[J]. Archives of Virology, 2007, 152(11):2017-25.
[93] Tallo T, Norder H, Tefanova V, et al. Hepatitis B virus genotype D strains from Estonia share sequence similarity with strains from Siberia and may specify ayw4[J]. J Med Virol, 2004, 74(2):221-7.
[94] K.Yalcin, H.Degertekin, I.H.Bahcecioglu, et al.Hepatitis B Virus Genotype D Prevails in Patients with Persistently Elevated or Normal ALT Levels in Turkey Turk[J]. J Gastroenterol,2005, 16(4):183-7.
[95] Norder H, Courouce AM, Coursaget P, et al.Genetic diversity of hepatitis B virus strains derived worldwide:genotypes, subgenotypes, and HBsAg subtypes[J].J Intervirology, 2004, 47(6):289-309.
[96] Mello FC, Souto FJ, Nabuco LC, et al. Hepatitis B virus genotypes circulating in Brazil:molecular characterization of genotype F isolates[J]. BMC Microbiol, 2007,23(7):103.
[97] Cui C, Shi J, Hui L, et al.The dominant hepatitis B virus genotype identified in Tibet is a C/D hybrid[J].J Gen Virol, 2002, 83(11):2773-7.
[98] Zeng G, Wang Z, Wen S, et al.Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China[J].J Viral Hepat, 2005, 12(6):609-17.
[99] Wang Z, Hou J, Zeng G, et al.Distribution and characteristics of hepatitis B virus genotype C subgenotypes in China[J].J Viral Hepat, 2007, 14(6):426-34.
[100]鲁晓擘,王晓岚,邓国宏,等.新疆维吾尔族慢性乙型肝炎患者HBV基因型分布及其特点[J].中华肝脏病杂志,2007, 15:241-4.
[101] Morozov V, Groudinin M, Groudinin M.Homologous recombination betweendifferent genotypes of hepatitis B virus[J]. Gene ,2000, 260(1-2):55-65.
[102] Yano, Yoshihiko; Truong, Bui X.;Seo, Yasushi, et al. Japanese case of hepatitis B virus genotypes C/D hybrid[J]. Hepatology Research, 2007, 37(12):1095-99 .
[103] Bottecchia M, Souto FJ, O KM, et al. Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy:characterization of genotype G in Brazil[J]. BMC Microbiol, 2008, 22(8):11.